<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201215</date><key>pmc.key</key><document><id>2780862</id><infon key="license">CC BY-NC-ND</infon><passage><infon key="article-id_doi">10.2337/db09-1003</infon><infon key="article-id_pmc">2780862</infon><infon key="article-id_pmid">19940235</infon><infon key="article-id_publisher-id">1003</infon><infon key="fpage">2718</infon><infon key="issue">12</infon><infon key="license">Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.</infon><infon key="lpage">2725</infon><infon key="name_0">surname:Ling;given-names:Charlotte</infon><infon key="name_1">surname:Groop;given-names:Leif</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">58</infon><infon key="year">2009</infon><offset>0</offset><text>Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>80</offset><text>Although obesity, reduced physical activity, and aging increase susceptibility to type 2 diabetes, many people exposed to these risk factors do not develop the disease. Recent genome-wide association studies have identified a number of genetic variants that explain some of the interindividual variation in diabetes susceptibility. There is also a growing body of literature suggesting a role for epigenetic factors in the complex interplay between genes and the environment. Nevertheless, our knowledge about the molecular mechanisms linking environmental factors and type 2 diabetes still remains limited. This perspective will provide some insights into epigenetic mechanisms associated with type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>792</offset><text>An overview of epigenetic regulation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>830</offset><text>Although there is no uniform definition of epigenetics, it has been described as heritable changes in gene function that occur without a change in the nucleotide sequence. Epigenetic modifications can be passed from one cell generation to the next (mitotic inheritance) and between generations of a species (meiotic inheritance). In plants, it is well established that epigenetic modifications can be inherited from one generation to the next. However, there is only limited information about the inheritance of epigenetic traits between generations in animals. Notably, epigenetic effects may also be affected by the environment, making them potentially important pathogenic mechanisms in complex multifactorial diseases such as type 2 diabetes (Fig. 1). Epigenetic factors include DNA methylations, histone modifications, and microRNAs, and they can help to explain how cells with identical DNA can differentiate into different cell types with different phenotypes. This perspective will focus on the roles of DNA methylation and histone modification in the pathogenesis of type 2 diabetes.</text></passage><passage><infon key="file">zdb0120959580001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>1923</offset><text>Model proposing a role for epigenetic mechanisms in the pathogenesis of type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2012</offset><text>Cytosine residues occurring in CG dinucleotides are targets for DNA methylation in vertebrates, and DNA methylation is associated with transcriptional silencing (e.g., on the inactive X chromosome). This silencing can be achieved by either repressing the binding of transcription factors (Fig. 2A) or by recruiting proteins that specifically bind to methylated CGs (methyl-CGâbinding proteins, e.g., MeCP2), which can further recruit histone deacetyltransferases (HDACs) and corepressors (Fig. 2B).</text></passage><passage><infon key="file">zdb0120959580002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>2513</offset><text>Effects of DNA methylation on gene expression. A: Whereas low levels of DNA methylation at gene promoters have been proposed to generate active genes through increased binding of transcription factors, elevated DNA methylation at promoters may inhibit binding of transcription factors resulting in inactive genes. B: DNA methylation at gene promoters may also repress gene transcription via specific proteins that bind to methylated CpGs (methyl-CpG binding proteins, e.g., MeCP2), and these proteins may then recruit HDACs and transcriptional corepressors (e.g., NCoR), resulting in an altered chromatin structure and inactive genes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3148</offset><text>DNA methylation requires the activity of methyltransferases. There are two groups of DNA methyltransferases: DNMT1, which copies the DNA methylation pattern between cell generations during replication (maintenance methylation), and DNMT3a and DNMT3b, which are responsible for de novo methylation of DNA. The process leading to demethylation of DNA is still poorly understood; for a recent review see Patra et al..</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3563</offset><text>Genomic DNA in eukaryotic cells is packed together with special proteins, termed histones, to form chromatin. The basic building block of chromatin is the nucleosome, which consists of â¼147 base pairs of DNA wrapped around an octamer of histone proteins that is composed of an H3-H4 tetramer flanked on either side with an H2A-H2B dimer. Although the core histones are densely packed, their NH2-terminal tails can be modified by histone- modifying enzymes, resulting in acetylation, methylation, phosphorylation, sumoylation, or ubiquitination. These modifications are important for determining the accessibility of the DNA to the transcription machinery as well as for replication, recombination, and chromosomal organization.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4293</offset><text>HDACs remove and histone acetyl transferases (HATs) add acetyl groups to lysine residues on histone tails. Although, it is well established that HAT activity and increased histone acetylation correlate with increased gene transcription, the exact mechanisms promoting transcription are less clear. Native lysine residues on histone tails contain a positive charge that can bind negatively charged DNA to form a condensed structure with low transcriptional activity. An early suggestion was that histone acetylation removes these positive charges, thereby relaxing chromatin structure and facilitating access to the DNA for the transcriptional machinery to initiate transcription. However, different models have recently been proposed, including the histone code hypothesis, where multiple histone modifications act in combination to regulate transcription. Histone acetylation may also recruit bromodomain proteins that can act as transcriptional activators. Histone methylation can result in either transcriptional activation or inactivation, depending on the degree of methylation and the specific lysine and/or arginine residues modified. Histone methyltransferases and histone demethylases mediate these processes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5512</offset><text>New techniques have made it easier to analyze DNA methylation and histone modifications on a genome-wide scale. These techniques may be useful when studying the impact of epigenetics on the pathogenesis of type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>5735</offset><text>Epigenetic changes induced by aging.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5772</offset><text>Aging is associated with an increased risk of type 2 diabetes. Correspondingly, oxidative capacity and mitochondrial function decline with age as well as in patients with type 2 diabetes. The mechanisms behind these defects may be both genetic and environmental. Recent data further suggest that the epigenetic pattern may change during the course of life, affecting key genes in the respiratory chain. COX7A1, which is part of complex 4 of the respiratory chain and which shows decreased expression in diabetic muscle, is a target of age-related DNA methylation. Whereas DNA methylation of the COX7A1 promoter is increased in skeletal muscle of elderly compared with young twins, the opposite pattern is found for COX7A1 gene expression. Additionally, the transcript level of COX7A1 in skeletal muscle is associated with increased in vivo glucose uptake and Vo2max. These data demonstrate how age can influence DNA methylation, gene expression, and subsequently in vivo metabolism. The interaction between nongenetic and epigenetic mechanisms may further be affected by genetic factors. Indeed, a polymorphism introducing a possible DNA methylation site, a CG dinucleotide, and a putative transcription factor binding site in the NDUFB6 promoter is associated with increased DNA methylation, decreased gene expression, and decreased in vivo metabolism with increasing age. This study provides an example of interactions between genetic (polymorphism), epigenetic (DNA methylation), and nongenetic (age) factors in the determination of human metabolism.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7326</offset><text>Hepatic insulin resistance is another important characteristic of both aging and type 2 diabetes. Glucokinase is a key enzyme in hepatic glucose utilization, and its activity is decreased in the liver of diabetic patients. Mutations in the glucokinase gene can cause a monogenic form of diabetes (maturity-onset diabetes of the young [MODY] 2). Moreover, in aged compared with young rats, the liver displays reduced levels of glucokinase expression and enzyme activity in parallel with increased DNA methylation of the glucokinase promoter. When hepatocytes of aged rats were cultured in vitro and the DNA was chemically demethylated, there was a substantial increase in glucokinase expression, suggesting an important role for DNA methylation in the age-related regulation of this gene. Similar studies in humans with diabetes are still lacking.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8173</offset><text>Although aging is associated with gene-specific hypermethylation, many mammalian tissues demonstrate global hypomethylation of DNA and decreased methyltransferase (DNMT1 and DNMT3a) expression with increased age. Global hypomethylation of DNA is seen in repetitive sequences and may promote genomic instability during aging. Increased age is also associated with hypomethylation of specific genes, e.g., proto-oncogenes, thereby increasing susceptibility to cancer, especially if combined with hypermethylation of tumor suppressor genes. Further studies examining the effects of aging on genome-wide epigenetic patterns in target tissues may help to improve our understanding of the molecular mechanisms influencing the pathogenesis of type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>8926</offset><text>Links between obesity, energy metabolism, nutrients, and epigenetic modifications.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9009</offset><text>The prevalence of type 2 diabetes is increasing rapidly worldwide, partly due to the epidemic in obesity seen among most ethnic groups. The fact that loss of function of the histone demethylase, Jhdm2a, is associated with obesity, decreased expression of metabolically active genes (e.g., peroxisome proliferatorâactivated receptor-Î± and medium-chain acyl-CoA dehydrogenase) in skeletal muscle, and an impaired cold-induced uncoupling protein 1 expression in brown adipose tissue in rodents suggests a relationship between epigenetic mechanisms and obesity. Another class of enzymes involved in epigenetic control of metabolism is the nicotinamide adenine dinucleotide (NAD+)-dependent sirtuins (class III HDACs), which target both histone and nonhistone proteins. The most well-characterized member, SIRT1, regulates several metabolic pathways including adipogenesis, mitochondrial biogenesis, glucose utilization, fat oxidation, and insulin secretion. Moreover, ATP-citrate lyase is an enzyme that regulates the conversion of citrate to acetyl CoA, which is a metabolite required for acetylation of histones by HATs. It has recently been suggested that glucose availability can affect histone acetylation in an ATP-citrate lyase-dependent manner, further linking energy metabolism to epigenetic regulation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10322</offset><text>Leptin is a hormone secreted from adipocytes that regulates appetite and energy homeostasis. It is predominantly expressed in mature adipocytes, and leptin expression can therefore be used as a marker of differentiating preadipocytes. The leptin promoter is embedded within a CG-rich region, called a CpG island. Although there is a high degree of DNA methylation of the leptin promoter and no leptin expression in preadipocytes, the promoter is demethylated in parallel with induction of leptin expression in differentiated cells. Although a high-fat diet increases DNA methylation of one CpG site in the leptin promoter of rat adipocytes, it remains to be examined whether food intake and obesity are associated with epigenetic regulation of leptin expression in human adipocytes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11105</offset><text>Environmental exposures to nutrients may change gene expression and alter disease susceptibility through epigenetic modifications. Similar mechanisms are operative in the agouti mouse; the agouti gene encodes a paracrine-signaling molecule that promotes melanocytes to produce yellow rather than black coat pigment and makes mice prone to develop obesity, diabetes, and tumors. The degree to which the agouti gene is methylated regulates agouti expression and thereby coat color and risk for disease. Moreover, supplementation of the diets of pregnant mice with methyl donors such as folic acid, vitamin B12, choline, or betaine increases DNA methylation of the gene in the offspring, resulting in low agouti expression and a brown coat color. The effect of maternal methyl-donor supplementation on coat color is also inherited in the F2 generation through germline epigenetic modifications.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11997</offset><text>Pdx1/insulin promoter factor (IPF)-1 is a transcription factor regulating pancreas development and Î²-cell differentiation, and mutations in this gene can cause a monogenic form of diabetes (MODY 4). Intrauterine growth retardation due to uteroplacental insufficiency has recently been associated with progressive epigenetic silencing of Pdx1, impaired Î²-cell function, and type 2 diabetes in adult offspring. Whether PDX1 is a target for similar epigenetic mechanisms in humans born to mothers with uteroplacental insufficiency remains unknown. However, the prenatal environment has been associated with insulin resistance and a risk for type 2 diabetes in humans, and the prenatal nutrient supply may induce epigenetic changes in humans. Indeed, individuals from the The Dutch Hunger Winter Families Study who were prenatally exposed to famine in 1944â1945 showed less DNA methylation of the imprinted IGF2 and INSIGF genes and increased DNA methylation of the GNASAS, MEG3, IL10, ABCA1, and LEP genes in parallel with impaired glucose tolerance compared with their unexposed same-sex siblings. Moreover, a high-fat diet during pregnancy in rats is associated with impaired glucose homeostasis and mitochondrial and cardiovascular dysfunctions in adult rats, possibly due to epigenetic modifications. In future studies it will be interesting to study the effects of short- and long-term weight gain and weight loss on epigenetic changes in relevant tissues.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>13462</offset><text>Histone modifications induced by exercise.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13505</offset><text>Poor physical fitness and a low Vo2max predict risk of developing type 2 diabetes. Mitochondrial dysfunction, changes in muscle fiberâtype composition, and insulin resistance are potential mechanisms linking poor physical fitness with an increased risk for disease. Exercise induces the expression of a number of genes that regulate glucose uptake in skeletal muscle, including GLUT isoform 4 (GLUT4),. GLUT4 expression is further regulated by the transcription factor myocyte enhancer factor 2 (MEF2).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14010</offset><text>At rest, it has been proposed that MEF2 interacts with HDAC5 in the nucleus. Histone tails at the GLUT4 gene are thereby deacetylated by HDAC5, resulting in a condense chromatin structure and subsequently reduced GLUT4 expression. After exercise, HDAC5 is phosphorylated by AMP-activated protein kinase, dissociated from MEF2, and exported from the nucleus to the cytosol. MEF2 may then interact with the coactivator protein PPARÎ³ coactivator-1Î± (PPARGC1A) and HATs in the nucleus, resulting in acetylated histones at the GLUT4 gene, enhanced transcriptional activity, and increased GLUT4 expression. It is possible that other histone modifications also influence the regulation of GLUT4 expression in skeletal muscle. Ca+/calmodulin-dependent protein kinase (CaMK) also seems to modulate MEF2 activity via histone acetylation in response to acute exercise. Moreover, gene expression of MYST4, a HAT, correlates positively with the percentage of type 1 fibers and Vo2max in human skeletal muscle. Together, these data suggest that some of the biological changes induced by exercise could be due to histone modifications, a research area that deserves further exploration.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>15190</offset><text>Epigenetic changes in patients with type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>15243</offset><text>Although data mining analysis has suggested a role for epigenetic factors in the pathogenesis of type 2 diabetes, there are only a limited number of studies that have examined epigenetic changes in target tissues from patients with type 2 diabetes. The transcriptional coactivator PPARGC1A coordinates gene expression that stimulates mitochondrial oxidative metabolism in multiple tissues. Whereas DNA methylation of the PPARGC1A promoter is elevated in pancreatic islets from patients with type 2 diabetes compared with that of healthy control subjects, PPARGC1A expression is reduced in diabetic islets and correlates inversely with the degree of DNA methylation. Importantly, PPARGC1A expression correlates positively with glucose-stimulated insulin secretion in human pancreatic islets, suggesting that epigenetic mechanisms may regulate gene expression and, subsequently, insulin secretion in human islets.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>16155</offset><text>Moreover, there have been some efforts to understand the epigenetic regulation of insulin gene expression in pancreatic Î²-cells. In Î²-cells, the insulin gene displays hyperacetylation of H4 and hypermethylation of H3 at lysine 4, typical of active genes; however, these epigenetic marks are not seen at the insulin gene in other cell types, e.g., HeLa cells. Furthermore, in a Î²-cell line, the HAT p300 and the histone methyltransferase SET7/9 are recruited to the insulin promoter to activate the gene. Interestingly, it has been suggested that HDACs influence pancreatic development in rodents because treatment with HDAC inhibitors during embryonic development enhances the pool of Î²-cells. However, it remains to be established whether any of these epigenetic marks in the insulin gene are affected in Î²-cells from patients with type 2 diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>17020</offset><text>Although pancreatic islet Î²-cell proliferation declines after birth, Î²-cell proliferation may play a role in the islets adaption to increased insulin demands imposed by insulin resistance. In support of this, an increased expression of Ink4a/Arf (Cdkn2a locus) was associated with reduced Î²-cell regeneration in aging mice. The elevated Ink4a/Arf expression in elderly mice further coincided with reduced levels of histone H3 lysine 27 trimethylation at Ink4a/Arf and the histone methyltransferase, Ezh2, together with decreased Bmi-1 binding and a loss of H2A ubiquitylation at Ink4a/Arf. Interestingly, a common variant at the CDKN2A locus has been associated with an increased risk for type 2 diabetes. However, whether this variant is associated with decreased Î²-cell proliferation in human islets remains unknown.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>17851</offset><text>Monogenic diabetes and epigenetic factors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>17894</offset><text>Most forms of MODY are caused by mutations in genes encoding transcription factors, including HNF1A, -4A, and -1B as well as IPF1/PDX1 and NEUROD1, some of which regulate transcription of their target genes through associations with HATs and HDACs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>18143</offset><text>HNF1Î± activates transcription through two different mechanisms: 1) recruitment of the general transcription machinery and 2) chromatin remodeling of promoter regions. The chromatin remodeling involves recruitment of HATs (e.g., p300/CBP), resulting in hyperacetylation of histones at specific promoters, including GLUT2 and pyruvate kinase, in Î²-cells. Interestingly, a missense mutation (R263L) in the HNF1A gene that is associated with a MODY phenotype results in reduced affinity for p300. Moreover, MODY mutations in the HNF1B gene influence the capacity of HNF1Î² to bind proteins with HAT activity and may thereby affect the chromatin structure.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>18804</offset><text>Whereas Pdx1 influences glucose-induced expression of insulin in Î²-cells, this regulation requires an interaction between Pdx1 and p300 and thereby hyperacetylation of histone H4 at the insulin gene promoter. It has been suggested that a low glucose level decreases insulin expression due to recruitment of HDAC1 and HDAC2 by Pdx1. Insulin transcription also involves methylation of histone H3 at the insulin promoter, possibly by Pdx1 recruiting methyltransferase SET9. Several PDX1 mutations associated with diabetes in humans modulate the affinity of PDX1 for both p300 and DNA. If operative in humans in vivo, this suggests that HAT activity and, therefore the chromatin structure of target genes may influence the risk for diabetes. NEUROD plays an important role in the development of the pancreas and regulates the transcription of insulin. One mutation in NEUROD, which results in a truncated protein and diabetes, also prevents it from binding to p300/CBP. Collectively, the data described above suggest mechanisms by which chromatin modifications can influence the risk of diabetes, which thereby opens new possible avenues for therapeutically preserving Î²-cell function.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>19992</offset><text>DNA methylation and transient neonatal diabetes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>20041</offset><text>Transient neonatal diabetes (TND) is a rare form of diabetes that begins in the first 6 weeks of life in growth-retarded neonates. Although insulin therapy is only required for an average of 3 months, the majority of these patients develop type 2 diabetes later in life. Three different chromosome 6 anomalies have been described in TND: hypomethylation at chromosome 6q24, paternally inherited duplication of 6q24, and paternal uniparental isodisomy of chromosome 6. Interestingly, it has recently been shown that mutations in a zinc-finger transcription factor, ZFP57, are associated with TND and hypomethylation of regions on 6q24, including the imprinted genes PLAGL1 and HYMAI.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>20724</offset><text>Epigenetic changes associated with diabetic complications.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>20783</offset><text>One major event in the progression of diabetic complications is vascular inflammation with increased expression of inflammatory genes. Enhanced oxidative stress, dyslipidemia, and hyperglycemia have also been suggested to influence the development of diabetic complications. Recent studies have proposed that hyperglycemia may induce epigenetic modifications of genes involved in vascular inflammation. Nuclear factor-ÎºB (NF-ÎºB) is a transcription factor regulating expression of genes involved in inflammatory diseases, including atherosclerosis and diabetic complications. Poor glycemic control increases NF-ÎºB activity in monocytes and thereby gene expression of inflammatory cytokines. This regulation involves an interaction between NF-ÎºB and HATs (e.g., CBP/p300), resulting in hyperacetylation of target genes including the tumor necrosis factor (TNF)-Î± and cyclooxygenase-2 promoters. The histone H3 lysine 4 methyltransferase SET7/9 can also influence the recruitment of NF-ÎºB p65 to gene promoters and thereby its regulation of proinflammatory genes. Moreover, vascular smooth muscle cells from diabetic db/db mice show decreased levels of histone H3 lysine 9 trimethylation (H3K9me3) and elevated levels of histone H3 lysine 4 dimethylation (H3K4me2) at the promoters of inflammatory genes, e.g., IL-6 and MCP-1, in parallel with decreased levels of the H3K9me3 methyltransferase Suv39h1 and a histone demethylase, the lysine-specific demethylase 1 (LSD1). Interestingly, whereas overexpression of Suv39h1 in vascular smooth muscle cells from diabetic db/db mice reversed the diabetic phenotype, gene silencing of SUV39H1 in normal human vascular smooth muscle cells increased the expression of inflammatory genes. NF-ÎºB and IL-6 also represent genes with altered histone H3 lysine 9 dimethylation in lymphocytes from patients with type 1 diabetes. Together, these studies suggest that hyperglycemia may induce epigenetic changes of proinflammatory genes, which subsequently regulate gene expression and thereby the development of vascular inflammation. However, improved glycemic control for 3â5 years in diabetic patients did not reduce the risk of macrovascular complications. One reason could be that the effects of hyperglycemia may be long-term and that epigenetic modifications induced by hyperglycemia may persist for more than 5 years. Moreover, because the time-averaged mean levels of glycemia, measured as A1C, only explain part of the variation in risk of developing diabetic complications, it was recently hypothesized that transient exposures to hyperglycemia may induce sustained epigenetic changes and thereby NF-ÎºBâregulated gene expression and increased risk for vascular complications over a longer period of time. Indeed, a transient exposure to hyperglycemia (16 h) induces epigenetic changes in the promoter of the NF-ÎºB subunit p65 and subsequently p65 expression and NF-ÎºB activity in aortic endothelial cells. These changes persist for 6 days during culture at normal glucose levels. Interestingly, when genes that reduce mitochondrial superoxide production (e.g., uncoupling protein-1) are overexpressed, the changes induced by the transient hyperglycemia are prevented. It was further shown that both a histone methylase (SET7) and a histone demethylase (LSD1) may regulate the epigenetic changes in the NF-ÎºB p65 promoter induced by transient hyperglycemia. In fact, epigenetic modifications induced by transient hyperglycemia may explain the hyperglycemic memory that has been proposed in epidemiological studies. In the future it may be possible that drugs using and/or affecting epigenetic mechanisms, e.g., HDAC inhibitors, can be used in the treatment of diabetic complications. In support of this idea, a recent study showed that myocardial infarction and ischemia induce HDAC activity in parallel with decreased histone acetylation of histone H3 and 4 in the heart. The use of chemical HDAC inhibitors during myocardial infarction reduced the infarct area as well as cell death.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>24853</offset><text>Conclusions.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>24866</offset><text>The use of genome-wide technologies to study gene expression and genetic variation in patients with type 2 diabetes has increased rapidly over the recent years, generating long lists of new type 2 diabetes candidate genes. However, the use of global techniques to study epigenetic modifications in these same patients has been limited. Epigenetic changes associated with type 2 diabetes are therefore still poorly understood. Nevertheless, epigenetics may play an important role in the growing incidence of type 2 diabetes, and over the next few years, it will be a great challenge to dissect the role of histone modifications and DNA methylation in the pathogenesis of the disease and its complications. Two additional important questions are whether the epigenetic changes induced by today's sedentary lifestyle can be inherited by coming generations and whether these changes are reversible. Currently, several epigenetic drugs are being tested in clinical trials or are already being used (e.g., anticancer or antiepileptic drugs); it may thus be possible to test epigenetic drugs as putative novel drugs for the treatment of diabetes and its complications.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>26028</offset><text>REFERENCES</text></passage><passage><infon key="fpage">1331</infon><infon key="lpage">1336</infon><infon key="name_0">surname:Saxena;given-names:R</infon><infon key="name_1">surname:Voight;given-names:BF</infon><infon key="name_10">surname:Hughes;given-names:TE</infon><infon key="name_11">surname:Groop;given-names:L</infon><infon key="name_12">surname:Altshuler;given-names:D</infon><infon key="name_13">surname:Almgren;given-names:P</infon><infon key="name_14">surname:Florez;given-names:JC</infon><infon key="name_15">surname:Meyer;given-names:J</infon><infon key="name_16">surname:Ardlie;given-names:K</infon><infon key="name_17">surname:Bengtsson BostrÃ¶m;given-names:K</infon><infon key="name_18">surname:Isomaa;given-names:B</infon><infon key="name_19">surname:Lettre;given-names:G</infon><infon key="name_2">surname:Lyssenko;given-names:V</infon><infon key="name_20">surname:Lindblad;given-names:U</infon><infon key="name_21">surname:Lyon;given-names:HN</infon><infon key="name_22">surname:Melander;given-names:O</infon><infon key="name_23">surname:Newton-Cheh;given-names:C</infon><infon key="name_24">surname:Nilsson;given-names:P</infon><infon key="name_25">surname:Orho-Melander;given-names:M</infon><infon key="name_26">surname:RÃ¥stam;given-names:L</infon><infon key="name_27">surname:Speliotes;given-names:EK</infon><infon key="name_28">surname:Taskinen;given-names:MR</infon><infon key="name_29">surname:Tuomi;given-names:T</infon><infon key="name_3">surname:Burtt;given-names:NP</infon><infon key="name_30">surname:Guiducci;given-names:C</infon><infon key="name_31">surname:Berglund;given-names:A</infon><infon key="name_32">surname:Carlson;given-names:J</infon><infon key="name_33">surname:Gianniny;given-names:L</infon><infon key="name_34">surname:Hackett;given-names:R</infon><infon key="name_35">surname:Hall;given-names:L</infon><infon key="name_36">surname:Holmkvist;given-names:J</infon><infon key="name_37">surname:Laurila;given-names:E</infon><infon key="name_38">surname:SjÃ¶gren;given-names:M</infon><infon key="name_39">surname:Sterner;given-names:M</infon><infon key="name_4">surname:de Bakker;given-names:PI</infon><infon key="name_40">surname:Surti;given-names:A</infon><infon key="name_41">surname:Svensson;given-names:M</infon><infon key="name_42">surname:Svensson;given-names:M</infon><infon key="name_43">surname:Tewhey;given-names:R</infon><infon key="name_44">surname:Blumenstiel;given-names:B</infon><infon key="name_45">surname:Parkin;given-names:M</infon><infon key="name_46">surname:Defelice;given-names:M</infon><infon key="name_47">surname:Barry;given-names:R</infon><infon key="name_48">surname:Brodeur;given-names:W</infon><infon key="name_49">surname:Camarata;given-names:J</infon><infon key="name_5">surname:Chen;given-names:H</infon><infon key="name_50">surname:Chia;given-names:N</infon><infon key="name_51">surname:Fava;given-names:M</infon><infon key="name_52">surname:Gibbons;given-names:J</infon><infon key="name_53">surname:Handsaker;given-names:B</infon><infon key="name_54">surname:Healy;given-names:C</infon><infon key="name_55">surname:Nguyen;given-names:K</infon><infon key="name_56">surname:Gates;given-names:C</infon><infon key="name_57">surname:Sougnez;given-names:C</infon><infon key="name_58">surname:Gage;given-names:D</infon><infon key="name_59">surname:Nizzari;given-names:M</infon><infon key="name_6">surname:Roix;given-names:JJ</infon><infon key="name_60">surname:Gabriel;given-names:SB</infon><infon key="name_61">surname:Chirn;given-names:GW</infon><infon key="name_62">surname:Ma;given-names:Q</infon><infon key="name_63">surname:Parikh;given-names:H</infon><infon key="name_64">surname:Richardson;given-names:D</infon><infon key="name_65">surname:Ricke;given-names:D</infon><infon key="name_66">surname:Purcell;given-names:S</infon><infon key="name_7">surname:Kathiresan;given-names:S</infon><infon key="name_8">surname:Hirschhorn;given-names:JN</infon><infon key="name_9">surname:Daly;given-names:MJ</infon><infon key="pub-id_pmid">17463246</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">316</infon><infon key="year">2007</infon><offset>26039</offset><text>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</text></passage><passage><infon key="fpage">1341</infon><infon key="lpage">1345</infon><infon key="name_0">surname:Scott;given-names:LJ</infon><infon key="name_1">surname:Mohlke;given-names:KL</infon><infon key="name_10">surname:Prokunina-Olsson;given-names:L</infon><infon key="name_11">surname:Ding;given-names:CJ</infon><infon key="name_12">surname:Swift;given-names:AJ</infon><infon key="name_13">surname:Narisu;given-names:N</infon><infon key="name_14">surname:Hu;given-names:T</infon><infon key="name_15">surname:Pruim;given-names:R</infon><infon key="name_16">surname:Xiao;given-names:R</infon><infon key="name_17">surname:Li;given-names:XY</infon><infon key="name_18">surname:Conneely;given-names:KN</infon><infon key="name_19">surname:Riebow;given-names:NL</infon><infon key="name_2">surname:Bonnycastle;given-names:LL</infon><infon key="name_20">surname:Sprau;given-names:AG</infon><infon key="name_21">surname:Tong;given-names:M</infon><infon key="name_22">surname:White;given-names:PP</infon><infon key="name_23">surname:Hetrick;given-names:KN</infon><infon key="name_24">surname:Barnhart;given-names:MW</infon><infon key="name_25">surname:Bark;given-names:CW</infon><infon key="name_26">surname:Goldstein;given-names:JL</infon><infon key="name_27">surname:Watkins;given-names:L</infon><infon key="name_28">surname:Xiang;given-names:F</infon><infon key="name_29">surname:Saramies;given-names:J</infon><infon key="name_3">surname:Willer;given-names:CJ</infon><infon key="name_30">surname:Buchanan;given-names:TA</infon><infon key="name_31">surname:Watanabe;given-names:RM</infon><infon key="name_32">surname:Valle;given-names:TT</infon><infon key="name_33">surname:Kinnunen;given-names:L</infon><infon key="name_34">surname:Abecasis;given-names:GR</infon><infon key="name_35">surname:Pugh;given-names:EW</infon><infon key="name_36">surname:Doheny;given-names:KF</infon><infon key="name_37">surname:Bergman;given-names:RN</infon><infon key="name_38">surname:Tuomilehto;given-names:J</infon><infon key="name_39">surname:Collins;given-names:FS</infon><infon key="name_4">surname:Li;given-names:Y</infon><infon key="name_40">surname:Boehnke;given-names:M</infon><infon key="name_5">surname:Duren;given-names:WL</infon><infon key="name_6">surname:Erdos;given-names:MR</infon><infon key="name_7">surname:Stringham;given-names:HM</infon><infon key="name_8">surname:Chines;given-names:PS</infon><infon key="name_9">surname:Jackson;given-names:AU</infon><infon key="pub-id_pmid">17463248</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">316</infon><infon key="year">2007</infon><offset>26132</offset><text>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</text></passage><passage><infon key="fpage">881</infon><infon key="lpage">885</infon><infon key="name_0">surname:Sladek;given-names:R</infon><infon key="name_1">surname:Rocheleau;given-names:G</infon><infon key="name_10">surname:Balkau;given-names:B</infon><infon key="name_11">surname:Heude;given-names:B</infon><infon key="name_12">surname:Charpentier;given-names:G</infon><infon key="name_13">surname:Hudson;given-names:TJ</infon><infon key="name_14">surname:Montpetit;given-names:A</infon><infon key="name_15">surname:Pshezhetsky;given-names:AV</infon><infon key="name_16">surname:Prentki;given-names:M</infon><infon key="name_17">surname:Posner;given-names:BI</infon><infon key="name_18">surname:Balding;given-names:DJ</infon><infon key="name_19">surname:Meyre;given-names:D</infon><infon key="name_2">surname:Rung;given-names:J</infon><infon key="name_20">surname:Polychronakos;given-names:C</infon><infon key="name_21">surname:Froguel;given-names:P</infon><infon key="name_3">surname:Dina;given-names:C</infon><infon key="name_4">surname:Shen;given-names:L</infon><infon key="name_5">surname:Serre;given-names:D</infon><infon key="name_6">surname:Boutin;given-names:P</infon><infon key="name_7">surname:Vincent;given-names:D</infon><infon key="name_8">surname:Belisle;given-names:A</infon><infon key="name_9">surname:Hadjadj;given-names:S</infon><infon key="pub-id_pmid">17293876</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">445</infon><infon key="year">2007</infon><offset>26233</offset><text>A genome-wide association study identifies novel risk loci for type 2 diabetes</text></passage><passage><infon key="fpage">1336</infon><infon key="lpage">1341</infon><infon key="name_0">surname:Zeggini;given-names:E</infon><infon key="name_1">surname:Weedon;given-names:MN</infon><infon key="name_10">surname:Barrett;given-names:JC</infon><infon key="name_11">surname:Shields;given-names:B</infon><infon key="name_12">surname:Morris;given-names:AP</infon><infon key="name_13">surname:Ellard;given-names:S</infon><infon key="name_14">surname:Groves;given-names:CJ</infon><infon key="name_15">surname:Harries;given-names:LW</infon><infon key="name_16">surname:Marchini;given-names:JL</infon><infon key="name_17">surname:Owen;given-names:KR</infon><infon key="name_18">surname:Knight;given-names:B</infon><infon key="name_19">surname:Cardon;given-names:LR</infon><infon key="name_2">surname:Lindgren;given-names:CM</infon><infon key="name_20">surname:Walker;given-names:M</infon><infon key="name_21">surname:Hitman;given-names:GA</infon><infon key="name_22">surname:Morris;given-names:AD</infon><infon key="name_23">surname:Doney;given-names:AS</infon><infon key="name_24">surname:McCarthy;given-names:MI</infon><infon key="name_25">surname:Hattersley;given-names:AT</infon><infon key="name_3">surname:Frayling;given-names:TM</infon><infon key="name_4">surname:Elliott;given-names:KS</infon><infon key="name_5">surname:Lango;given-names:H</infon><infon key="name_6">surname:Timpson;given-names:NJ</infon><infon key="name_7">surname:Perry;given-names:JR</infon><infon key="name_8">surname:Rayner;given-names:NW</infon><infon key="name_9">surname:Freathy;given-names:RM</infon><infon key="pub-id_pmid">17463249</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">316</infon><infon key="year">2007</infon><offset>26312</offset><text>Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes</text></passage><passage><infon key="fpage">638</infon><infon key="lpage">645</infon><infon key="name_0">surname:Zeggini;given-names:E</infon><infon key="name_1">surname:Scott;given-names:LJ</infon><infon key="name_10">surname:Ardlie;given-names:K</infon><infon key="name_11">surname:BostrÃ¶m;given-names:KB</infon><infon key="name_12">surname:Bergman;given-names:RN</infon><infon key="name_13">surname:Bonnycastle;given-names:LL</infon><infon key="name_14">surname:Borch-Johnsen;given-names:K</infon><infon key="name_15">surname:Burtt;given-names:NP</infon><infon key="name_16">surname:Chen;given-names:H</infon><infon key="name_17">surname:Chines;given-names:PS</infon><infon key="name_18">surname:Daly;given-names:MJ</infon><infon key="name_19">surname:Deodhar;given-names:P</infon><infon key="name_2">surname:Saxena;given-names:R</infon><infon key="name_20">surname:Ding;given-names:CJ</infon><infon key="name_21">surname:Doney;given-names:AS</infon><infon key="name_22">surname:Duren;given-names:WL</infon><infon key="name_23">surname:Elliott;given-names:KS</infon><infon key="name_24">surname:Erdos;given-names:MR</infon><infon key="name_25">surname:Frayling;given-names:TM</infon><infon key="name_26">surname:Freathy;given-names:RM</infon><infon key="name_27">surname:Gianniny;given-names:L</infon><infon key="name_28">surname:Grallert;given-names:H</infon><infon key="name_29">surname:Grarup;given-names:N</infon><infon key="name_3">surname:Voight;given-names:BF</infon><infon key="name_30">surname:Groves;given-names:CJ</infon><infon key="name_31">surname:Guiducci;given-names:C</infon><infon key="name_32">surname:Hansen;given-names:T</infon><infon key="name_33">surname:Herder;given-names:C</infon><infon key="name_34">surname:Hitman;given-names:GA</infon><infon key="name_35">surname:Hughes;given-names:TE</infon><infon key="name_36">surname:Isomaa;given-names:B</infon><infon key="name_37">surname:Jackson;given-names:AU</infon><infon key="name_38">surname:JÃ¸rgensen;given-names:T</infon><infon key="name_39">surname:Kong;given-names:A</infon><infon key="name_4">surname:Marchini;given-names:JL</infon><infon key="name_40">surname:Kubalanza;given-names:K</infon><infon key="name_41">surname:Kuruvilla;given-names:FG</infon><infon key="name_42">surname:Kuusisto;given-names:J</infon><infon key="name_43">surname:Langenberg;given-names:C</infon><infon key="name_44">surname:Lango;given-names:H</infon><infon key="name_45">surname:Lauritzen;given-names:T</infon><infon key="name_46">surname:Li;given-names:Y</infon><infon key="name_47">surname:Lindgren;given-names:CM</infon><infon key="name_48">surname:Lyssenko;given-names:V</infon><infon key="name_49">surname:Marvelle;given-names:AF</infon><infon key="name_5">surname:Hu;given-names:T</infon><infon key="name_50">surname:Meisinger;given-names:C</infon><infon key="name_51">surname:Midthjell;given-names:K</infon><infon key="name_52">surname:Mohlke;given-names:KL</infon><infon key="name_53">surname:Morken;given-names:MA</infon><infon key="name_54">surname:Morris;given-names:AD</infon><infon key="name_55">surname:Narisu;given-names:N</infon><infon key="name_56">surname:Nilsson;given-names:P</infon><infon key="name_57">surname:Owen;given-names:KR</infon><infon key="name_58">surname:Palmer;given-names:CN</infon><infon key="name_59">surname:Payne;given-names:F</infon><infon key="name_6">surname:de Bakker;given-names:PI</infon><infon key="name_60">surname:Perry;given-names:JR</infon><infon key="name_61">surname:Pettersen;given-names:E</infon><infon key="name_62">surname:Platou;given-names:C</infon><infon key="name_63">surname:Prokopenko;given-names:I</infon><infon key="name_64">surname:Qi;given-names:L</infon><infon key="name_65">surname:Qin;given-names:L</infon><infon key="name_66">surname:Rayner;given-names:NW</infon><infon key="name_67">surname:Rees;given-names:M</infon><infon key="name_68">surname:Roix;given-names:JJ</infon><infon key="name_69">surname:Sandbaek;given-names:A</infon><infon key="name_7">surname:Abecasis;given-names:GR</infon><infon key="name_70">surname:Shields;given-names:B</infon><infon key="name_71">surname:SjÃ¶gren;given-names:M</infon><infon key="name_72">surname:Steinthorsdottir;given-names:V</infon><infon key="name_73">surname:Stringham;given-names:HM</infon><infon key="name_74">surname:Swift;given-names:AJ</infon><infon key="name_75">surname:Thorleifsson;given-names:G</infon><infon key="name_76">surname:Thorsteinsdottir;given-names:U</infon><infon key="name_77">surname:Timpson;given-names:NJ</infon><infon key="name_78">surname:Tuomi;given-names:T</infon><infon key="name_79">surname:Tuomilehto;given-names:J</infon><infon key="name_8">surname:Almgren;given-names:P</infon><infon key="name_80">surname:Walker;given-names:M</infon><infon key="name_81">surname:Watanabe;given-names:RM</infon><infon key="name_82">surname:Weedon;given-names:MN</infon><infon key="name_83">surname:Willer;given-names:CJ</infon><infon key="name_84">surname:Illig;given-names:T</infon><infon key="name_85">surname:Hveem;given-names:K</infon><infon key="name_86">surname:Hu;given-names:FB</infon><infon key="name_87">surname:Laakso;given-names:M</infon><infon key="name_88">surname:Stefansson;given-names:K</infon><infon key="name_89">surname:Pedersen;given-names:O</infon><infon key="name_9">surname:Andersen;given-names:G</infon><infon key="name_90">surname:Wareham;given-names:NJ</infon><infon key="name_91">surname:Barroso;given-names:I</infon><infon key="name_92">surname:Hattersley;given-names:AT</infon><infon key="name_93">surname:Collins;given-names:FS</infon><infon key="name_94">surname:Groop;given-names:L</infon><infon key="name_95">surname:McCarthy;given-names:MI</infon><infon key="name_96">surname:Boehnke;given-names:M</infon><infon key="name_97">surname:Altshuler;given-names:D</infon><infon key="pub-id_pmid">18372903</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2008</infon><offset>26411</offset><text>Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes</text></passage><passage><infon key="fpage">396</infon><infon key="lpage">398</infon><infon key="name_0">surname:Bird;given-names:A</infon><infon key="pub-id_pmid">17522671</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">447</infon><infon key="year">2007</infon><offset>26547</offset><text>Perceptions of epigenetics</text></passage><passage><infon key="fpage">157</infon><infon key="lpage">161</infon><infon key="name_0">surname:Cubas;given-names:P</infon><infon key="name_1">surname:Vincent;given-names:C</infon><infon key="name_2">surname:Coen;given-names:E</infon><infon key="pub-id_pmid">10490023</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">401</infon><infon key="year">1999</infon><offset>26574</offset><text>An epigenetic mutation responsible for natural variation in floral symmetry</text></passage><passage><infon key="fpage">692</infon><infon key="lpage">696</infon><infon key="name_0">surname:Chong;given-names:S</infon><infon key="name_1">surname:Whitelaw;given-names:E</infon><infon key="pub-id_pmid">15531166</infon><infon key="section_type">REF</infon><infon key="source">Curr Opin Genet Dev</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2004</infon><offset>26650</offset><text>Epigenetic germline inheritance</text></passage><passage><infon key="fpage">1466</infon><infon key="lpage">1469</infon><infon key="name_0">surname:Anway;given-names:MD</infon><infon key="name_1">surname:Cupp;given-names:AS</infon><infon key="name_2">surname:Uzumcu;given-names:M</infon><infon key="name_3">surname:Skinner;given-names:MK</infon><infon key="pub-id_pmid">15933200</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">308</infon><infon key="year">2005</infon><offset>26682</offset><text>Epigenetic transgenerational actions of endocrine disruptors and male fertility</text></passage><passage><infon key="fpage">1509</infon><infon key="lpage">1522</infon><infon key="name_0">surname:Clouaire;given-names:T</infon><infon key="name_1">surname:Stancheva;given-names:I</infon><infon key="pub-id_pmid">18322651</infon><infon key="section_type">REF</infon><infon key="source">Cell Mol Life Sci</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2008</infon><offset>26762</offset><text>Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?</text></passage><passage><infon key="fpage">315</infon><infon key="lpage">334</infon><infon key="name_0">surname:Patra;given-names:SK</infon><infon key="name_1">surname:Patra;given-names:A</infon><infon key="name_2">surname:Rizzi;given-names:F</infon><infon key="name_3">surname:Ghosh;given-names:TC</infon><infon key="name_4">surname:Bettuzzi;given-names:S</infon><infon key="pub-id_pmid">18246412</infon><infon key="section_type">REF</infon><infon key="source">Cancer Metastasis Rev</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2008</infon><offset>26869</offset><text>Demethylation of (cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development</text></passage><passage><infon key="fpage">693</infon><infon key="lpage">705</infon><infon key="name_0">surname:Kouzarides;given-names:T</infon><infon key="pub-id_pmid">17320507</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">128</infon><infon key="year">2007</infon><offset>26993</offset><text>Chromatin modifications and their function</text></passage><passage><infon key="fpage">32</infon><infon key="lpage">42</infon><infon key="name_0">surname:Haberland;given-names:M</infon><infon key="name_1">surname:Montgomery;given-names:RL</infon><infon key="name_2">surname:Olson;given-names:EN</infon><infon key="pub-id_pmid">19065135</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Genet</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2009</infon><offset>27036</offset><text>The many roles of histone deacetylases in development and physiology: implications for disease and therapy</text></passage><passage><infon key="fpage">5395</infon><infon key="lpage">5407</infon><infon key="name_0">surname:Avvakumov;given-names:N</infon><infon key="name_1">surname:CÃ´tÃ©;given-names:J</infon><infon key="pub-id_pmid">17694081</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2007</infon><offset>27143</offset><text>The MYST family of histone acetyltransferases and their intimate links to cancer</text></passage><passage><infon key="fpage">75</infon><infon key="lpage">100</infon><infon key="name_0">surname:Shahbazian;given-names:MD</infon><infon key="name_1">surname:Grunstein;given-names:M</infon><infon key="pub-id_pmid">17362198</infon><infon key="section_type">REF</infon><infon key="source">Annu Rev Biochem</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="year">2007</infon><offset>27224</offset><text>Functions of site-specific histone acetylation and deacetylation</text></passage><passage><infon key="fpage">897</infon><infon key="lpage">903</infon><infon key="name_0">surname:Wang;given-names:Z</infon><infon key="name_1">surname:Zang;given-names:C</infon><infon key="name_10">surname:Zhao;given-names:K</infon><infon key="name_2">surname:Rosenfeld;given-names:JA</infon><infon key="name_3">surname:Schones;given-names:DE</infon><infon key="name_4">surname:Barski;given-names:A</infon><infon key="name_5">surname:Cuddapah;given-names:S</infon><infon key="name_6">surname:Cui;given-names:K</infon><infon key="name_7">surname:Roh;given-names:TY</infon><infon key="name_8">surname:Peng;given-names:W</infon><infon key="name_9">surname:Zhang;given-names:MQ</infon><infon key="pub-id_pmid">18552846</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2008</infon><offset>27289</offset><text>Combinatorial patterns of histone acetylations and methylations in the human genome</text></passage><passage><infon key="fpage">711</infon><infon key="lpage">721</infon><infon key="name_0">surname:BÃ¡rtovÃ¡;given-names:E</infon><infon key="name_1">surname:KrejcÃ­;given-names:J</infon><infon key="name_2">surname:HarnicarovÃ¡;given-names:A</infon><infon key="name_3">surname:GaliovÃ¡;given-names:G</infon><infon key="name_4">surname:Kozubek;given-names:S</infon><infon key="pub-id_pmid">18474937</infon><infon key="section_type">REF</infon><infon key="source">J Histochem Cytochem</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2008</infon><offset>27373</offset><text>Histone modifications and nuclear architecture: a review</text></passage><passage><infon key="fpage">58</infon><infon key="lpage">68</infon><infon key="name_0">surname:Marmorstein;given-names:R</infon><infon key="name_1">surname:Trievel;given-names:RC</infon><infon key="pub-id_pmid">18722564</infon><infon key="section_type">REF</infon><infon key="source">Biochim Biophys Acta</infon><infon key="type">ref</infon><infon key="volume">1789</infon><infon key="year">2009</infon><offset>27430</offset><text>Histone modifying enzymes: structures, mechanisms, and specificities</text></passage><passage><infon key="fpage">465</infon><infon key="lpage">476</infon><infon key="name_0">surname:Suzuki;given-names:MM</infon><infon key="name_1">surname:Bird;given-names:A</infon><infon key="pub-id_pmid">18463664</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Genet</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2008</infon><offset>27499</offset><text>DNA methylation landscapes: provocative insights from epigenomics</text></passage><passage><infon key="fpage">863</infon><infon key="lpage">868</infon><infon key="name_0">surname:Lennartsson;given-names:A</infon><infon key="name_1">surname:Ekwall;given-names:K</infon><infon key="pub-id_pmid">19168116</infon><infon key="section_type">REF</infon><infon key="source">Biochim Biophys Acta</infon><infon key="type">ref</infon><infon key="volume">1790</infon><infon key="year">2009</infon><offset>27565</offset><text>Histone modification patterns and epigenetic codes</text></passage><passage><infon key="fpage">1140</infon><infon key="lpage">1142</infon><infon key="name_0">surname:Petersen;given-names:KF</infon><infon key="name_1">surname:Befroy;given-names:D</infon><infon key="name_2">surname:Dufour;given-names:S</infon><infon key="name_3">surname:Dziura;given-names:J</infon><infon key="name_4">surname:Ariyan;given-names:C</infon><infon key="name_5">surname:Rothman;given-names:DL</infon><infon key="name_6">surname:DiPietro;given-names:L</infon><infon key="name_7">surname:Cline;given-names:GW</infon><infon key="name_8">surname:Shulman;given-names:GI</infon><infon key="pub-id_pmid">12750520</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="year">2003</infon><offset>27616</offset><text>Mitochondrial dysfunction in the elderly: possible role in insulin resistance</text></passage><passage><infon key="fpage">664</infon><infon key="lpage">671</infon><infon key="name_0">surname:Petersen;given-names:KF</infon><infon key="name_1">surname:Dufour;given-names:S</infon><infon key="name_2">surname:Befroy;given-names:D</infon><infon key="name_3">surname:Garcia;given-names:R</infon><infon key="name_4">surname:Shulman;given-names:GI</infon><infon key="pub-id_pmid">14960743</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">350</infon><infon key="year">2004</infon><offset>27694</offset><text>Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes</text></passage><passage><infon key="fpage">267</infon><infon key="lpage">273</infon><infon key="name_0">surname:Mootha;given-names:VK</infon><infon key="name_1">surname:Lindgren;given-names:CM</infon><infon key="name_10">surname:Houstis;given-names:N</infon><infon key="name_11">surname:Daly;given-names:MJ</infon><infon key="name_12">surname:Patterson;given-names:N</infon><infon key="name_13">surname:Mesirov;given-names:JP</infon><infon key="name_14">surname:Golub;given-names:TR</infon><infon key="name_15">surname:Tamayo;given-names:P</infon><infon key="name_16">surname:Spiegelman;given-names:B</infon><infon key="name_17">surname:Lander;given-names:ES</infon><infon key="name_18">surname:Hirschhorn;given-names:JN</infon><infon key="name_19">surname:Altshuler;given-names:D</infon><infon key="name_2">surname:Eriksson;given-names:KF</infon><infon key="name_20">surname:Groop;given-names:LC</infon><infon key="name_3">surname:Subramanian;given-names:A</infon><infon key="name_4">surname:Sihag;given-names:S</infon><infon key="name_5">surname:Lehar;given-names:J</infon><infon key="name_6">surname:Puigserver;given-names:P</infon><infon key="name_7">surname:Carlsson;given-names:E</infon><infon key="name_8">surname:RidderstrÃ¥le;given-names:M</infon><infon key="name_9">surname:Laurila;given-names:E</infon><infon key="pub-id_pmid">12808457</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2003</infon><offset>27794</offset><text>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</text></passage><passage><infon key="fpage">8466</infon><infon key="lpage">8471</infon><infon key="name_0">surname:Patti;given-names:ME</infon><infon key="name_1">surname:Butte;given-names:AJ</infon><infon key="name_10">surname:Landaker;given-names:EJ</infon><infon key="name_11">surname:Goldfine;given-names:AB</infon><infon key="name_12">surname:Mun;given-names:E</infon><infon key="name_13">surname:DeFronzo;given-names:R</infon><infon key="name_14">surname:Finlayson;given-names:J</infon><infon key="name_15">surname:Kahn;given-names:CR</infon><infon key="name_16">surname:Mandarino;given-names:LJ</infon><infon key="name_2">surname:Crunkhorn;given-names:S</infon><infon key="name_3">surname:Cusi;given-names:K</infon><infon key="name_4">surname:Berria;given-names:R</infon><infon key="name_5">surname:Kashyap;given-names:S</infon><infon key="name_6">surname:Miyazaki;given-names:Y</infon><infon key="name_7">surname:Kohane;given-names:I</infon><infon key="name_8">surname:Costello;given-names:M</infon><infon key="name_9">surname:Saccone;given-names:R</infon><infon key="pub-id_pmid">12832613</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">2003</infon><offset>27909</offset><text>Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1</text></passage><passage><infon key="fpage">2944</infon><infon key="lpage">2950</infon><infon key="name_0">surname:Kelley;given-names:DE</infon><infon key="name_1">surname:He;given-names:J</infon><infon key="name_2">surname:Menshikova;given-names:EV</infon><infon key="name_3">surname:Ritov;given-names:VB</infon><infon key="pub-id_pmid">12351431</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2002</infon><offset>28044</offset><text>Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes</text></passage><passage><infon key="fpage">8</infon><infon key="lpage">14</infon><infon key="name_0">surname:Ritov;given-names:VB</infon><infon key="name_1">surname:Menshikova;given-names:EV</infon><infon key="name_2">surname:He;given-names:J</infon><infon key="name_3">surname:Ferrell;given-names:RE</infon><infon key="name_4">surname:Goodpaster;given-names:BH</infon><infon key="name_5">surname:Kelley;given-names:DE</infon><infon key="pub-id_pmid">15616005</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2005</infon><offset>28116</offset><text>Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes</text></passage><passage><infon key="fpage">1518</infon><infon key="lpage">1526</infon><infon key="name_0">surname:Ling;given-names:C</infon><infon key="name_1">surname:Poulsen;given-names:P</infon><infon key="name_2">surname:Carlsson;given-names:E</infon><infon key="name_3">surname:RidderstrÃ¥le;given-names:M</infon><infon key="name_4">surname:Almgren;given-names:P</infon><infon key="name_5">surname:Wojtaszewski;given-names:J</infon><infon key="name_6">surname:Beck-Nielsen;given-names:H</infon><infon key="name_7">surname:Groop;given-names:L</infon><infon key="name_8">surname:Vaag;given-names:A</infon><infon key="pub-id_pmid">15546003</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">114</infon><infon key="year">2004</infon><offset>28189</offset><text>Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins</text></passage><passage><infon key="fpage">1615</infon><infon key="lpage">1620</infon><infon key="name_0">surname:Ling;given-names:C</infon><infon key="name_1">surname:Wegner;given-names:L</infon><infon key="name_2">surname:Andersen;given-names:G</infon><infon key="name_3">surname:Almgren;given-names:P</infon><infon key="name_4">surname:Hansen;given-names:T</infon><infon key="name_5">surname:Pedersen;given-names:O</infon><infon key="name_6">surname:Groop;given-names:L</infon><infon key="name_7">surname:Vaag;given-names:A</infon><infon key="name_8">surname:Poulsen;given-names:P</infon><infon key="pub-id_pmid">17579828</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2007</infon><offset>28308</offset><text>Impact of the peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) Ala203Pro polymorphism on in vivo metabolism, PGC-1beta expression and fibre type composition in human skeletal muscle</text></passage><passage><infon key="fpage">e4793</infon><infon key="name_0">surname:Ronn;given-names:T</infon><infon key="name_1">surname:Poulsen;given-names:P</infon><infon key="name_2">surname:Tuomi;given-names:T</infon><infon key="name_3">surname:Isomaa;given-names:B</infon><infon key="name_4">surname:Groop;given-names:L</infon><infon key="name_5">surname:Vaag;given-names:A</infon><infon key="name_6">surname:Ling;given-names:C</infon><infon key="pub-id_pmid">19274082</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2009</infon><offset>28520</offset><text>Genetic variation in ATP5O is associated with skeletal muscle ATP50 mRNA expression and glucose uptake in young twins</text></passage><passage><infon key="fpage">481</infon><infon key="lpage">484</infon><infon key="name_0">surname:Kujoth;given-names:GC</infon><infon key="name_1">surname:Hiona;given-names:A</infon><infon key="name_10">surname:Morrow;given-names:JD</infon><infon key="name_11">surname:Van Remmen;given-names:H</infon><infon key="name_12">surname:Sedivy;given-names:JM</infon><infon key="name_13">surname:Yamasoba;given-names:T</infon><infon key="name_14">surname:Tanokura;given-names:M</infon><infon key="name_15">surname:Weindruch;given-names:R</infon><infon key="name_16">surname:Leeuwenburgh;given-names:C</infon><infon key="name_17">surname:Prolla;given-names:TA</infon><infon key="name_2">surname:Pugh;given-names:TD</infon><infon key="name_3">surname:Someya;given-names:S</infon><infon key="name_4">surname:Panzer;given-names:K</infon><infon key="name_5">surname:Wohlgemuth;given-names:SE</infon><infon key="name_6">surname:Hofer;given-names:T</infon><infon key="name_7">surname:Seo;given-names:AY</infon><infon key="name_8">surname:Sullivan;given-names:R</infon><infon key="name_9">surname:Jobling;given-names:WA</infon><infon key="pub-id_pmid">16020738</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">309</infon><infon key="year">2005</infon><offset>28638</offset><text>Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging</text></passage><passage><infon key="fpage">469</infon><infon key="lpage">480</infon><infon key="name_0">surname:Bua;given-names:E</infon><infon key="name_1">surname:Johnson;given-names:J</infon><infon key="name_2">surname:Herbst;given-names:A</infon><infon key="name_3">surname:Delong;given-names:B</infon><infon key="name_4">surname:McKenzie;given-names:D</infon><infon key="name_5">surname:Salamat;given-names:S</infon><infon key="name_6">surname:Aiken;given-names:JM</infon><infon key="pub-id_pmid">16909385</infon><infon key="section_type">REF</infon><infon key="source">Am J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">2006</infon><offset>28718</offset><text>Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers</text></passage><passage><infon key="fpage">10604</infon><infon key="lpage">10609</infon><infon key="name_0">surname:Fraga;given-names:MF</infon><infon key="name_1">surname:Ballestar;given-names:E</infon><infon key="name_10">surname:Boix-Chornet;given-names:M</infon><infon key="name_11">surname:Sanchez-Aguilera;given-names:A</infon><infon key="name_12">surname:Ling;given-names:C</infon><infon key="name_13">surname:Carlsson;given-names:E</infon><infon key="name_14">surname:Poulsen;given-names:P</infon><infon key="name_15">surname:Vaag;given-names:A</infon><infon key="name_16">surname:Stephan;given-names:Z</infon><infon key="name_17">surname:Spector;given-names:TD</infon><infon key="name_18">surname:Wu;given-names:YZ</infon><infon key="name_19">surname:Plass;given-names:C</infon><infon key="name_2">surname:Paz;given-names:MF</infon><infon key="name_20">surname:Esteller;given-names:M</infon><infon key="name_3">surname:Ropero;given-names:S</infon><infon key="name_4">surname:Setien;given-names:F</infon><infon key="name_5">surname:Ballestar;given-names:ML</infon><infon key="name_6">surname:Heine-SuÃ±er;given-names:D</infon><infon key="name_7">surname:Cigudosa;given-names:JC</infon><infon key="name_8">surname:Urioste;given-names:M</infon><infon key="name_9">surname:Benitez;given-names:J</infon><infon key="pub-id_pmid">16009939</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2005</infon><offset>28841</offset><text>Epigenetic differences arise during the lifetime of monozygotic twins</text></passage><passage><infon key="fpage">3427</infon><infon key="lpage">3435</infon><infon key="name_0">surname:Ling;given-names:C</infon><infon key="name_1">surname:Poulsen;given-names:P</infon><infon key="name_10">surname:Vaag;given-names:A</infon><infon key="name_11">surname:Groop;given-names:L</infon><infon key="name_2">surname:Simonsson;given-names:S</infon><infon key="name_3">surname:RÃ¶nn;given-names:T</infon><infon key="name_4">surname:Holmkvist;given-names:J</infon><infon key="name_5">surname:Almgren;given-names:P</infon><infon key="name_6">surname:Hagert;given-names:P</infon><infon key="name_7">surname:Nilsson;given-names:E</infon><infon key="name_8">surname:Mabey;given-names:AG</infon><infon key="name_9">surname:Nilsson;given-names:P</infon><infon key="pub-id_pmid">17948130</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">117</infon><infon key="year">2007</infon><offset>28911</offset><text>Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle</text></passage><passage><infon key="fpage">1159</infon><infon key="lpage">1168</infon><infon key="name_0">surname:RÃ¶nn;given-names:T</infon><infon key="name_1">surname:Poulsen;given-names:P</infon><infon key="name_10">surname:Ling;given-names:C</infon><infon key="name_2">surname:Hansson;given-names:O</infon><infon key="name_3">surname:Holmkvist;given-names:J</infon><infon key="name_4">surname:Almgren;given-names:P</infon><infon key="name_5">surname:Nilsson;given-names:P</infon><infon key="name_6">surname:Tuomi;given-names:T</infon><infon key="name_7">surname:Isomaa;given-names:B</infon><infon key="name_8">surname:Groop;given-names:L</infon><infon key="name_9">surname:Vaag;given-names:A</infon><infon key="pub-id_pmid">18488190</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2008</infon><offset>29036</offset><text>Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle</text></passage><passage><infon key="fpage">19</infon><infon key="lpage">22</infon><infon key="name_0">surname:Caro;given-names:JF</infon><infon key="name_1">surname:Triester;given-names:S</infon><infon key="name_2">surname:Patel;given-names:VK</infon><infon key="name_3">surname:Tapscott;given-names:EB</infon><infon key="name_4">surname:Frazier;given-names:NL</infon><infon key="name_5">surname:Dohm;given-names:GL</infon><infon key="pub-id_pmid">7729787</infon><infon key="section_type">REF</infon><infon key="source">Horm Metab Res</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">1995</infon><offset>29122</offset><text>Liver glucokinase: decreased activity in patients with type II diabetes</text></passage><passage><infon key="fpage">254</infon><infon key="lpage">264</infon><infon key="name_0">surname:Vaxillaire;given-names:M</infon><infon key="name_1">surname:Froguel;given-names:P</infon><infon key="pub-id_pmid">18436708</infon><infon key="section_type">REF</infon><infon key="source">Endocr Rev</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2008</infon><offset>29194</offset><text>Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes</text></passage><passage><infon key="fpage">1525</infon><infon key="lpage">1533</infon><infon key="name_0">surname:Jiang;given-names:MH</infon><infon key="name_1">surname:Fei;given-names:J</infon><infon key="name_2">surname:Lan;given-names:MS</infon><infon key="name_3">surname:Lu;given-names:ZP</infon><infon key="name_4">surname:Liu;given-names:M</infon><infon key="name_5">surname:Fan;given-names:WW</infon><infon key="name_6">surname:Gao;given-names:X</infon><infon key="name_7">surname:Lu;given-names:DR</infon><infon key="pub-id_pmid">18496667</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2008</infon><offset>29301</offset><text>Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential</text></passage><passage><infon key="fpage">8681</infon><infon key="lpage">8686</infon><infon key="name_0">surname:Toyota;given-names:M</infon><infon key="name_1">surname:Ahuja;given-names:N</infon><infon key="name_2">surname:Ohe-Toyota;given-names:M</infon><infon key="name_3">surname:Herman;given-names:JG</infon><infon key="name_4">surname:Baylin;given-names:SB</infon><infon key="name_5">surname:Issa;given-names:JP</infon><infon key="pub-id_pmid">10411935</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">1999</infon><offset>29395</offset><text>CpG island methylator phenotype in colorectal cancer</text></passage><passage><infon key="comment">discussion 153â155</infon><infon key="fpage">140</infon><infon key="lpage">153</infon><infon key="name_0">surname:Issa;given-names:JP</infon><infon key="pub-id_pmid">10911911</infon><infon key="section_type">REF</infon><infon key="source">Ann N Y Acad Sci</infon><infon key="type">ref</infon><infon key="volume">910</infon><infon key="year">2000</infon><offset>29448</offset><text>The epigenetics of colorectal cancer</text></passage><passage><infon key="fpage">103</infon><infon key="lpage">108</infon><infon key="name_0">surname:Issa;given-names:JP</infon><infon key="pub-id_pmid">14585281</infon><infon key="section_type">REF</infon><infon key="source">Clin Immunol</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2003</infon><offset>29485</offset><text>Age-related epigenetic changes and the immune system</text></passage><passage><infon key="fpage">82</infon><infon key="lpage">86</infon><infon key="name_0">surname:Youssef;given-names:EM</infon><infon key="name_1">surname:Estecio;given-names:MR</infon><infon key="name_2">surname:Issa;given-names:JP</infon><infon key="pub-id_pmid">14726683</infon><infon key="section_type">REF</infon><infon key="source">Cancer Biol Ther</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>29538</offset><text>Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer</text></passage><passage><infon key="fpage">201</infon><infon key="lpage">208</infon><infon key="name_0">surname:Burzynski;given-names:SR</infon><infon key="pub-id_pmid">15533642</infon><infon key="section_type">REF</infon><infon key="source">Med Hypotheses</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2005</infon><offset>29651</offset><text>Aging: gene silencing or gene activation?</text></passage><passage><infon key="fpage">1257</infon><infon key="lpage">1268</infon><infon key="name_0">surname:Zhang;given-names:Z</infon><infon key="name_1">surname:Deng;given-names:C</infon><infon key="name_2">surname:Lu;given-names:Q</infon><infon key="name_3">surname:Richardson;given-names:B</infon><infon key="pub-id_pmid">12020947</infon><infon key="section_type">REF</infon><infon key="source">Mech Ageing Dev</infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">2002</infon><offset>29693</offset><text>Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter</text></passage><passage><infon key="fpage">1055</infon><infon key="lpage">1057</infon><infon key="name_0">surname:Wilson;given-names:VL</infon><infon key="name_1">surname:Jones;given-names:PA</infon><infon key="pub-id_pmid">6844925</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">220</infon><infon key="year">1983</infon><offset>29761</offset><text>DNA methylation decreases in aging but not in immortal cells</text></passage><passage><infon key="fpage">9948</infon><infon key="lpage">9951</infon><infon key="name_0">surname:Wilson;given-names:VL</infon><infon key="name_1">surname:Smith;given-names:RA</infon><infon key="name_2">surname:Ma;given-names:S</infon><infon key="name_3">surname:Cutler;given-names:RG</infon><infon key="pub-id_pmid">3611071</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">262</infon><infon key="year">1987</infon><offset>29822</offset><text>Genomic 5-methyldeoxycytidine decreases with age</text></passage><passage><infon key="fpage">757</infon><infon key="lpage">761</infon><infon key="name_0">surname:Tateishi;given-names:K</infon><infon key="name_1">surname:Okada;given-names:Y</infon><infon key="name_2">surname:Kallin;given-names:EM</infon><infon key="name_3">surname:Zhang;given-names:Y</infon><infon key="pub-id_pmid">19194461</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">458</infon><infon key="year">2009</infon><offset>29871</offset><text>Role of Jhdm2a in regulating metabolic gene expression and obesity resistance</text></passage><passage><infon key="fpage">104</infon><infon key="lpage">112</infon><infon key="name_0">surname:Schwer;given-names:B</infon><infon key="name_1">surname:Verdin;given-names:E</infon><infon key="pub-id_pmid">18249170</infon><infon key="section_type">REF</infon><infon key="source">Cell Metab</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2008</infon><offset>29949</offset><text>Conserved metabolic regulatory functions of sirtuins</text></passage><passage><infon key="fpage">1076</infon><infon key="lpage">1080</infon><infon key="name_0">surname:Wellen;given-names:KE</infon><infon key="name_1">surname:Hatzivassiliou;given-names:G</infon><infon key="name_2">surname:Sachdeva;given-names:UM</infon><infon key="name_3">surname:Bui;given-names:TV</infon><infon key="name_4">surname:Cross;given-names:JR</infon><infon key="name_5">surname:Thompson;given-names:CB</infon><infon key="pub-id_pmid">19461003</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">324</infon><infon key="year">2009</infon><offset>30002</offset><text>ATP-citrate lyase links cellular metabolism to histone acetylation</text></passage><passage><infon key="fpage">45420</infon><infon key="lpage">45427</infon><infon key="name_0">surname:Melzner;given-names:I</infon><infon key="name_1">surname:Scott;given-names:V</infon><infon key="name_2">surname:Dorsch;given-names:K</infon><infon key="name_3">surname:Fischer;given-names:P</infon><infon key="name_4">surname:Wabitsch;given-names:M</infon><infon key="name_5">surname:BrÃ¼derlein;given-names:S</infon><infon key="name_6">surname:Hasel;given-names:C</infon><infon key="name_7">surname:MÃ¶ller;given-names:P</infon><infon key="pub-id_pmid">12213831</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">277</infon><infon key="year">2002</infon><offset>30069</offset><text>Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter</text></passage><passage><infon key="fpage">140</infon><infon key="lpage">148</infon><infon key="name_0">surname:Yokomori;given-names:N</infon><infon key="name_1">surname:Tawata;given-names:M</infon><infon key="name_2">surname:Onaya;given-names:T</infon><infon key="pub-id_pmid">11845234</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2002</infon><offset>30208</offset><text>DNA demethylation modulates mouse leptin promoter activity during the differentiation of 3T3âL1 cells</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">9</infon><infon key="name_0">surname:Milagro;given-names:FI</infon><infon key="name_1">surname:CampiÃ³n;given-names:J</infon><infon key="name_2">surname:GarcÃ­a-DÃ­az;given-names:DF</infon><infon key="name_3">surname:Goyenechea;given-names:E</infon><infon key="name_4">surname:Paternain;given-names:L</infon><infon key="name_5">surname:MartÃ­nez;given-names:JA</infon><infon key="pub-id_pmid">19588726</infon><infon key="section_type">REF</infon><infon key="source">J Physiol Biochem</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2009</infon><offset>30312</offset><text>High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats</text></passage><passage><infon key="fpage">59</infon><infon key="lpage">65</infon><infon key="name_0">surname:Duhl;given-names:DM</infon><infon key="name_1">surname:Vrieling;given-names:H</infon><infon key="name_2">surname:Miller;given-names:KA</infon><infon key="name_3">surname:Wolff;given-names:GL</infon><infon key="name_4">surname:Barsh;given-names:GS</infon><infon key="pub-id_pmid">7987393</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">1994</infon><offset>30402</offset><text>Neomorphic agouti mutations in obese yellow mice</text></passage><passage><infon key="fpage">314</infon><infon key="lpage">318</infon><infon key="name_0">surname:Morgan;given-names:HD</infon><infon key="name_1">surname:Sutherland;given-names:HG</infon><infon key="name_2">surname:Martin;given-names:DI</infon><infon key="name_3">surname:Whitelaw;given-names:E</infon><infon key="pub-id_pmid">10545949</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1999</infon><offset>30451</offset><text>Epigenetic inheritance at the agouti locus in the mouse</text></passage><passage><infon key="fpage">949</infon><infon key="lpage">957</infon><infon key="name_0">surname:Wolff;given-names:GL</infon><infon key="name_1">surname:Kodell;given-names:RL</infon><infon key="name_2">surname:Moore;given-names:SR</infon><infon key="name_3">surname:Cooney;given-names:CA</infon><infon key="pub-id_pmid">9707167</infon><infon key="section_type">REF</infon><infon key="source">Faseb J</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1998</infon><offset>30507</offset><text>Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice</text></passage><passage><infon key="fpage">253</infon><infon key="lpage">262</infon><infon key="name_0">surname:Jirtle;given-names:RL</infon><infon key="name_1">surname:Skinner;given-names:MK</infon><infon key="pub-id_pmid">17363974</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Genet</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2007</infon><offset>30595</offset><text>Environmental epigenomics and disease susceptibility</text></passage><passage><infon key="fpage">17308</infon><infon key="lpage">17312</infon><infon key="name_0">surname:Cropley;given-names:JE</infon><infon key="name_1">surname:Suter;given-names:CM</infon><infon key="name_2">surname:Beckman;given-names:KB</infon><infon key="name_3">surname:Martin;given-names:DI</infon><infon key="pub-id_pmid">17101998</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2006</infon><offset>30648</offset><text>Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation</text></passage><passage><infon key="fpage">2316</infon><infon key="lpage">2324</infon><infon key="name_0">surname:Park;given-names:JH</infon><infon key="name_1">surname:Stoffers;given-names:DA</infon><infon key="name_2">surname:Nicholls;given-names:RD</infon><infon key="name_3">surname:Simmons;given-names:RA</infon><infon key="pub-id_pmid">18464933</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">118</infon><infon key="year">2008</infon><offset>30739</offset><text>Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1</text></passage><passage><infon key="fpage">1271</infon><infon key="lpage">1280</infon><infon key="name_0">surname:Jensen;given-names:CB</infon><infon key="name_1">surname:Storgaard;given-names:H</infon><infon key="name_2">surname:Dela;given-names:F</infon><infon key="name_3">surname:Holst;given-names:JJ</infon><infon key="name_4">surname:Madsbad;given-names:S</infon><infon key="name_5">surname:Vaag;given-names:AA</infon><infon key="pub-id_pmid">11916955</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2002</infon><offset>30880</offset><text>Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight</text></passage><passage><infon key="fpage">1530</infon><infon key="lpage">1534</infon><infon key="name_0">surname:Jensen;given-names:CB</infon><infon key="name_1">surname:Storgaard;given-names:H</infon><infon key="name_2">surname:Madsbad;given-names:S</infon><infon key="name_3">surname:Richter;given-names:EA</infon><infon key="name_4">surname:Vaag;given-names:AA</infon><infon key="pub-id_pmid">17284623</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">2007</infon><offset>30993</offset><text>Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight</text></passage><passage><infon key="fpage">173</infon><infon key="lpage">177</infon><infon key="name_0">surname:Ravelli;given-names:AC</infon><infon key="name_1">surname:van der Meulen;given-names:JH</infon><infon key="name_2">surname:Michels;given-names:RP</infon><infon key="name_3">surname:Osmond;given-names:C</infon><infon key="name_4">surname:Barker;given-names:DJ</infon><infon key="name_5">surname:Hales;given-names:CN</infon><infon key="name_6">surname:Bleker;given-names:OP</infon><infon key="pub-id_pmid">9449872</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">351</infon><infon key="year">1998</infon><offset>31117</offset><text>Glucose tolerance in adults after prenatal exposure to famine</text></passage><passage><infon key="fpage">1196</infon><infon key="lpage">1204</infon><infon key="name_0">surname:Lumey;given-names:LH</infon><infon key="name_1">surname:Stein;given-names:AD</infon><infon key="name_2">surname:Kahn;given-names:HS</infon><infon key="name_3">surname:van der Pal-de Bruin;given-names:KM</infon><infon key="name_4">surname:Blauw;given-names:GJ</infon><infon key="name_5">surname:Zybert;given-names:PA</infon><infon key="name_6">surname:Susser;given-names:ES</infon><infon key="pub-id_pmid">17591638</infon><infon key="section_type">REF</infon><infon key="source">Int J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2007</infon><offset>31179</offset><text>Cohort profile: the Dutch Hunger Winter families study</text></passage><passage><infon key="fpage">17046</infon><infon key="lpage">17049</infon><infon key="name_0">surname:Heijmans;given-names:BT</infon><infon key="name_1">surname:Tobi;given-names:EW</infon><infon key="name_2">surname:Stein;given-names:AD</infon><infon key="name_3">surname:Putter;given-names:H</infon><infon key="name_4">surname:Blauw;given-names:GJ</infon><infon key="name_5">surname:Susser;given-names:ES</infon><infon key="name_6">surname:Slagboom;given-names:PE</infon><infon key="name_7">surname:Lumey;given-names:LH</infon><infon key="pub-id_pmid">18955703</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">2008</infon><offset>31234</offset><text>Persistent epigenetic differences associated with prenatal exposure to famine in humans</text></passage><passage><infon key="fpage">4046</infon><infon key="lpage">4053</infon><infon key="name_0">surname:Tobi;given-names:EW</infon><infon key="name_1">surname:Lumey;given-names:LH</infon><infon key="name_2">surname:Talens;given-names:RP</infon><infon key="name_3">surname:Kremer;given-names:D</infon><infon key="name_4">surname:Putter;given-names:H</infon><infon key="name_5">surname:Stein;given-names:AD</infon><infon key="name_6">surname:Slagboom;given-names:PE</infon><infon key="name_7">surname:Heijmans;given-names:BT</infon><infon key="pub-id_pmid">19656776</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2009</infon><offset>31322</offset><text>DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific</text></passage><passage><infon key="fpage">459</infon><infon key="lpage">464</infon><infon key="name_0">surname:Armitage;given-names:JA</infon><infon key="name_1">surname:Pearce;given-names:AD</infon><infon key="name_2">surname:Sinclair;given-names:AJ</infon><infon key="name_3">surname:Vingrys;given-names:AJ</infon><infon key="name_4">surname:Weisinger;given-names:RS</infon><infon key="name_5">surname:Weisinger;given-names:HS</infon><infon key="pub-id_pmid">12848294</infon><infon key="section_type">REF</infon><infon key="source">Lipids</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2003</infon><offset>31424</offset><text>Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency</text></passage><passage><infon key="fpage">R127</infon><infon key="lpage">R133</infon><infon key="name_0">surname:Khan;given-names:IY</infon><infon key="name_1">surname:Dekou;given-names:V</infon><infon key="name_2">surname:Douglas;given-names:G</infon><infon key="name_3">surname:Jensen;given-names:R</infon><infon key="name_4">surname:Hanson;given-names:MA</infon><infon key="name_5">surname:Poston;given-names:L</infon><infon key="name_6">surname:Taylor;given-names:PD</infon><infon key="pub-id_pmid">15308487</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Regul Integr Comp Physiol</infon><infon key="type">ref</infon><infon key="volume">288</infon><infon key="year">2005</infon><offset>31522</offset><text>A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring</text></passage><passage><infon key="fpage">R134</infon><infon key="lpage">R139</infon><infon key="name_0">surname:Taylor;given-names:PD</infon><infon key="name_1">surname:McConnell;given-names:J</infon><infon key="name_10">surname:Poston;given-names:L</infon><infon key="name_2">surname:Khan;given-names:IY</infon><infon key="name_3">surname:Holemans;given-names:K</infon><infon key="name_4">surname:Lawrence;given-names:KM</infon><infon key="name_5">surname:Asare-Anane;given-names:H</infon><infon key="name_6">surname:Persaud;given-names:SJ</infon><infon key="name_7">surname:Jones;given-names:PM</infon><infon key="name_8">surname:Petrie;given-names:L</infon><infon key="name_9">surname:Hanson;given-names:MA</infon><infon key="pub-id_pmid">15388492</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Regul Integr Comp Physiol</infon><infon key="type">ref</infon><infon key="volume">288</infon><infon key="year">2005</infon><offset>31625</offset><text>Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy</text></passage><passage><infon key="fpage">573</infon><infon key="lpage">579</infon><infon key="name_0">surname:Eriksson;given-names:KF</infon><infon key="name_1">surname:LindgÃ¤rde;given-names:F</infon><infon key="pub-id_pmid">8739917</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1996</infon><offset>31740</offset><text>Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men</text></passage><passage><infon key="fpage">C1597</infon><infon key="lpage">C1603</infon><infon key="name_0">surname:Neufer;given-names:PD</infon><infon key="name_1">surname:Dohm;given-names:GL</infon><infon key="pub-id_pmid">7506491</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol</infon><infon key="type">ref</infon><infon key="volume">265</infon><infon key="year">1993</infon><offset>31877</offset><text>Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle</text></passage><passage><infon key="fpage">395</infon><infon key="lpage">399</infon><infon key="name_0">surname:McGee;given-names:SL</infon><infon key="name_1">surname:Hargreaves;given-names:M</infon><infon key="pub-id_pmid">16620308</infon><infon key="section_type">REF</infon><infon key="source">Clin Exp Pharmacol Physiol</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2006</infon><offset>31970</offset><text>Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms</text></passage><passage><infon key="fpage">860</infon><infon key="lpage">867</infon><infon key="name_0">surname:McGee;given-names:SL</infon><infon key="name_1">surname:van Denderen;given-names:BJ</infon><infon key="name_2">surname:Howlett;given-names:KF</infon><infon key="name_3">surname:Mollica;given-names:J</infon><infon key="name_4">surname:Schertzer;given-names:JD</infon><infon key="name_5">surname:Kemp;given-names:BE</infon><infon key="name_6">surname:Hargreaves;given-names:M</infon><infon key="pub-id_pmid">18184930</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2008</infon><offset>32054</offset><text>AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5</text></passage><passage><infon key="fpage">1208</infon><infon key="lpage">1214</infon><infon key="name_0">surname:McGee;given-names:SL</infon><infon key="name_1">surname:Hargreaves;given-names:M</infon><infon key="pub-id_pmid">15111488</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">2004</infon><offset>32154</offset><text>Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle</text></passage><passage><infon key="fpage">348</infon><infon key="lpage">349</infon><infon key="name_0">surname:McGee;given-names:SL</infon><infon key="name_1">surname:Sparling;given-names:D</infon><infon key="name_2">surname:Olson;given-names:AL</infon><infon key="name_3">surname:Hargreaves;given-names:M</infon><infon key="pub-id_pmid">16368714</infon><infon key="section_type">REF</infon><infon key="source">Faseb J</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2006</infon><offset>32229</offset><text>Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle</text></passage><passage><infon key="fpage">E408</infon><infon key="lpage">E415</infon><infon key="name_0">surname:Vissing;given-names:K</infon><infon key="name_1">surname:McGee;given-names:SL</infon><infon key="name_2">surname:Roepstorff;given-names:C</infon><infon key="name_3">surname:Schjerling;given-names:P</infon><infon key="name_4">surname:Hargreaves;given-names:M</infon><infon key="name_5">surname:Kiens;given-names:B</infon><infon key="pub-id_pmid">18042665</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">294</infon><infon key="year">2008</infon><offset>32308</offset><text>Effect of sex differences on human MEF2 regulation during endurance exercise</text></passage><passage><infon key="fpage">E698</infon><infon key="lpage">E704</infon><infon key="name_0">surname:Smith;given-names:JA</infon><infon key="name_1">surname:Kohn;given-names:TA</infon><infon key="name_2">surname:Chetty;given-names:AK</infon><infon key="name_3">surname:Ojuka;given-names:EO</infon><infon key="pub-id_pmid">18647882</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">295</infon><infon key="year">2008</infon><offset>32385</offset><text>CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene</text></passage><passage><infon key="fpage">E1152</infon><infon key="lpage">E1159</infon><infon key="name_0">surname:Parikh;given-names:H</infon><infon key="name_1">surname:Nilsson;given-names:E</infon><infon key="name_2">surname:Ling;given-names:C</infon><infon key="name_3">surname:Poulsen;given-names:P</infon><infon key="name_4">surname:Almgren;given-names:P</infon><infon key="name_5">surname:Nittby;given-names:H</infon><infon key="name_6">surname:Eriksson;given-names:KF</infon><infon key="name_7">surname:Vaag;given-names:A</infon><infon key="name_8">surname:Groop;given-names:LC</infon><infon key="pub-id_pmid">18445752</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">294</infon><infon key="year">2008</infon><offset>32511</offset><text>Molecular correlates for maximal oxygen uptake and type 1 fibers</text></passage><passage><infon key="fpage">104</infon><infon key="lpage">112</infon><infon key="name_0">surname:Wren;given-names:JD</infon><infon key="name_1">surname:Garner;given-names:HR</infon><infon key="pub-id_pmid">16046815</infon><infon key="section_type">REF</infon><infon key="source">J Biomed Biotechnol</infon><infon key="type">ref</infon><infon key="volume">2005</infon><infon key="year">2005</infon><offset>32576</offset><text>Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes</text></passage><passage><infon key="fpage">78</infon><infon key="lpage">90</infon><infon key="name_0">surname:Puigserver;given-names:P</infon><infon key="name_1">surname:Spiegelman;given-names:BM</infon><infon key="pub-id_pmid">12588810</infon><infon key="section_type">REF</infon><infon key="source">Endocr Rev</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2003</infon><offset>32653</offset><text>Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator</text></passage><passage><infon key="fpage">615</infon><infon key="lpage">622</infon><infon key="name_0">surname:Ling;given-names:C</infon><infon key="name_1">surname:Del Guerra;given-names:S</infon><infon key="name_2">surname:Lupi;given-names:R</infon><infon key="name_3">surname:RÃ¶nn;given-names:T</infon><infon key="name_4">surname:Granhall;given-names:C</infon><infon key="name_5">surname:Luthman;given-names:H</infon><infon key="name_6">surname:Masiello;given-names:P</infon><infon key="name_7">surname:Marchetti;given-names:P</infon><infon key="name_8">surname:Groop;given-names:L</infon><infon key="name_9">surname:Del Prato;given-names:S</infon><infon key="pub-id_pmid">18270681</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2008</infon><offset>32789</offset><text>Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion</text></passage><passage><infon key="fpage">3223</infon><infon key="lpage">3233</infon><infon key="name_0">surname:Mutskov;given-names:V</infon><infon key="name_1">surname:Raaka;given-names:BM</infon><infon key="name_2">surname:Felsenfeld;given-names:G</infon><infon key="name_3">surname:Gershengorn;given-names:MC</infon><infon key="pub-id_pmid">17901401</infon><infon key="section_type">REF</infon><infon key="source">Stem Cells</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2007</infon><offset>32887</offset><text>The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression</text></passage><passage><infon key="fpage">23617</infon><infon key="lpage">23623</infon><infon key="name_0">surname:Chakrabarti;given-names:SK</infon><infon key="name_1">surname:Francis;given-names:J</infon><infon key="name_2">surname:Ziesmann;given-names:SM</infon><infon key="name_3">surname:Garmey;given-names:JC</infon><infon key="name_4">surname:Mirmira;given-names:RG</infon><infon key="pub-id_pmid">12711597</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">278</infon><infon key="year">2003</infon><offset>33043</offset><text>Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells</text></passage><passage><infon key="fpage">6373</infon><infon key="lpage">6383</infon><infon key="name_0">surname:Haumaitre;given-names:C</infon><infon key="name_1">surname:Lenoir;given-names:O</infon><infon key="name_2">surname:Scharfmann;given-names:R</infon><infon key="pub-id_pmid">18710955</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2008</infon><offset>33167</offset><text>Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors</text></passage><passage><infon key="fpage">453</infon><infon key="lpage">457</infon><infon key="name_0">surname:Krishnamurthy;given-names:J</infon><infon key="name_1">surname:Ramsey;given-names:MR</infon><infon key="name_2">surname:Ligon;given-names:KL</infon><infon key="name_3">surname:Torrice;given-names:C</infon><infon key="name_4">surname:Koh;given-names:A</infon><infon key="name_5">surname:Bonner-Weir;given-names:S</infon><infon key="name_6">surname:Sharpless;given-names:NE</infon><infon key="pub-id_pmid">16957737</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">443</infon><infon key="year">2006</infon><offset>33274</offset><text>p16INK4a induces an age-dependent decline in islet regenerative potential</text></passage><passage><infon key="fpage">975</infon><infon key="lpage">985</infon><infon key="name_0">surname:Chen;given-names:H</infon><infon key="name_1">surname:Gu;given-names:X</infon><infon key="name_2">surname:Su;given-names:IH</infon><infon key="name_3">surname:Bottino;given-names:R</infon><infon key="name_4">surname:Contreras;given-names:JL</infon><infon key="name_5">surname:Tarakhovsky;given-names:A</infon><infon key="name_6">surname:Kim;given-names:SK</infon><infon key="pub-id_pmid">19390090</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2009</infon><offset>33348</offset><text>Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus</text></passage><passage><infon key="fpage">906</infon><infon key="lpage">911</infon><infon key="name_0">surname:Dhawan;given-names:S</infon><infon key="name_1">surname:Tschen;given-names:SI</infon><infon key="name_2">surname:Bhushan;given-names:A</infon><infon key="pub-id_pmid">19390085</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2009</infon><offset>33460</offset><text>Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation</text></passage><passage><infon key="fpage">4948</infon><infon key="lpage">4956</infon><infon key="name_0">surname:Pontoglio;given-names:M</infon><infon key="name_1">surname:Faust;given-names:DM</infon><infon key="name_2">surname:Doyen;given-names:A</infon><infon key="name_3">surname:Yaniv;given-names:M</infon><infon key="name_4">surname:Weiss;given-names:MC</infon><infon key="pub-id_pmid">9271373</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1997</infon><offset>33542</offset><text>Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene</text></passage><passage><infon key="fpage">12515</infon><infon key="lpage">12520</infon><infon key="name_0">surname:Soutoglou;given-names:E</infon><infon key="name_1">surname:Papafotiou;given-names:G</infon><infon key="name_2">surname:Katrakili;given-names:N</infon><infon key="name_3">surname:Talianidis;given-names:I</infon><infon key="pub-id_pmid">10777539</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">275</infon><infon key="year">2000</infon><offset>33678</offset><text>Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins</text></passage><passage><infon key="fpage">3234</infon><infon key="lpage">3243</infon><infon key="name_0">surname:PÃ¡rrizas;given-names:M</infon><infon key="name_1">surname:Maestro;given-names:MA</infon><infon key="name_2">surname:Boj;given-names:SF</infon><infon key="name_3">surname:Paniagua;given-names:A</infon><infon key="name_4">surname:Casamitjana;given-names:R</infon><infon key="name_5">surname:Gomis;given-names:R</infon><infon key="name_6">surname:Rivera;given-names:F</infon><infon key="name_7">surname:Ferrer;given-names:J</infon><infon key="pub-id_pmid">11287626</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2001</infon><offset>33793</offset><text>Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets</text></passage><passage><infon key="fpage">1409</infon><infon key="lpage">1418</infon><infon key="name_0">surname:Ban;given-names:N</infon><infon key="name_1">surname:Yamada;given-names:Y</infon><infon key="name_2">surname:Someya;given-names:Y</infon><infon key="name_3">surname:Miyawaki;given-names:K</infon><infon key="name_4">surname:Ihara;given-names:Y</infon><infon key="name_5">surname:Hosokawa;given-names:M</infon><infon key="name_6">surname:Toyokuni;given-names:S</infon><infon key="name_7">surname:Tsuda;given-names:K</infon><infon key="name_8">surname:Seino;given-names:Y</infon><infon key="pub-id_pmid">11978637</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2002</infon><offset>33908</offset><text>Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter</text></passage><passage><infon key="fpage">721</infon><infon key="lpage">727</infon><infon key="name_0">surname:Kim;given-names:KA</infon><infon key="name_1">surname:Kang;given-names:K</infon><infon key="name_2">surname:Chi;given-names:YI</infon><infon key="name_3">surname:Chang;given-names:I</infon><infon key="name_4">surname:Lee;given-names:MK</infon><infon key="name_5">surname:Kim;given-names:KW</infon><infon key="name_6">surname:Shoelson;given-names:SE</infon><infon key="name_7">surname:Lee;given-names:MS</infon><infon key="pub-id_pmid">12712243</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2003</infon><offset>34015</offset><text>Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3</text></passage><passage><infon key="fpage">3139</infon><infon key="lpage">3149</infon><infon key="name_0">surname:Barbacci;given-names:E</infon><infon key="name_1">surname:Chalkiadaki;given-names:A</infon><infon key="name_2">surname:Masdeu;given-names:C</infon><infon key="name_3">surname:Haumaitre;given-names:C</infon><infon key="name_4">surname:Lokmane;given-names:L</infon><infon key="name_5">surname:Loirat;given-names:C</infon><infon key="name_6">surname:Cloarec;given-names:S</infon><infon key="name_7">surname:Talianidis;given-names:I</infon><infon key="name_8">surname:Bellanne-Chantelot;given-names:C</infon><infon key="name_9">surname:Cereghini;given-names:S</infon><infon key="pub-id_pmid">15509593</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2004</infon><offset>34153</offset><text>HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitment</text></passage><passage><infon key="fpage">412</infon><infon key="lpage">420</infon><infon key="name_0">surname:Qiu;given-names:Y</infon><infon key="name_1">surname:Guo;given-names:M</infon><infon key="name_2">surname:Huang;given-names:S</infon><infon key="name_3">surname:Stein;given-names:R</infon><infon key="pub-id_pmid">11756538</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2002</infon><offset>34251</offset><text>Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47</text></passage><passage><infon key="fpage">2918</infon><infon key="lpage">2928</infon><infon key="name_0">surname:Stanojevic;given-names:V</infon><infon key="name_1">surname:Habener;given-names:JF</infon><infon key="name_2">surname:Thomas;given-names:MK</infon><infon key="pub-id_pmid">15001545</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">145</infon><infon key="year">2004</infon><offset>34361</offset><text>Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300</text></passage><passage><infon key="fpage">19660</infon><infon key="lpage">19666</infon><infon key="name_0">surname:Mosley;given-names:AL</infon><infon key="name_1">surname:Ozcan;given-names:S</infon><infon key="pub-id_pmid">12665509</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">278</infon><infon key="year">2003</infon><offset>34449</offset><text>Glucose regulates insulin gene transcription by hyperacetylation of histone h4</text></passage><passage><infon key="fpage">54241</infon><infon key="lpage">54247</infon><infon key="name_0">surname:Mosley;given-names:AL</infon><infon key="name_1">surname:Ozcan;given-names:S</infon><infon key="pub-id_pmid">15496408</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2004</infon><offset>34528</offset><text>The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose</text></passage><passage><infon key="fpage">36244</infon><infon key="lpage">36253</infon><infon key="name_0">surname:Francis;given-names:J</infon><infon key="name_1">surname:Chakrabarti;given-names:SK</infon><infon key="name_2">surname:Garmey;given-names:JC</infon><infon key="name_3">surname:Mirmira;given-names:RG</infon><infon key="pub-id_pmid">16141209</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">280</infon><infon key="year">2005</infon><offset>34658</offset><text>Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription</text></passage><passage><infon key="fpage">323</infon><infon key="lpage">328</infon><infon key="name_0">surname:Malecki;given-names:MT</infon><infon key="name_1">surname:Jhala;given-names:US</infon><infon key="name_2">surname:Antonellis;given-names:A</infon><infon key="name_3">surname:Fields;given-names:L</infon><infon key="name_4">surname:Doria;given-names:A</infon><infon key="name_5">surname:Orban;given-names:T</infon><infon key="name_6">surname:Saad;given-names:M</infon><infon key="name_7">surname:Warram;given-names:JH</infon><infon key="name_8">surname:Montminy;given-names:M</infon><infon key="name_9">surname:Krolewski;given-names:AS</infon><infon key="pub-id_pmid">10545951</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1999</infon><offset>34774</offset><text>Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus</text></passage><passage><infon key="fpage">872</infon><infon key="lpage">875</infon><infon key="name_0">surname:Temple;given-names:IK</infon><infon key="name_1">surname:Shield;given-names:JP</infon><infon key="pub-id_pmid">12471198</infon><infon key="section_type">REF</infon><infon key="source">J Med Genet</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2002</infon><offset>34859</offset><text>Transient neonatal diabetes, a disorder of imprinting</text></passage><passage><infon key="fpage">949</infon><infon key="lpage">951</infon><infon key="name_0">surname:Mackay;given-names:DJ</infon><infon key="name_1">surname:Callaway;given-names:JL</infon><infon key="name_10">surname:Hahnemann;given-names:JM</infon><infon key="name_11">surname:Kordonouri;given-names:O</infon><infon key="name_12">surname:Masoud;given-names:AF</infon><infon key="name_13">surname:Oestergaard;given-names:E</infon><infon key="name_14">surname:Storr;given-names:J</infon><infon key="name_15">surname:Ellard;given-names:S</infon><infon key="name_16">surname:Hattersley;given-names:AT</infon><infon key="name_17">surname:Robinson;given-names:DO</infon><infon key="name_18">surname:Temple;given-names:IK</infon><infon key="name_2">surname:Marks;given-names:SM</infon><infon key="name_3">surname:White;given-names:HE</infon><infon key="name_4">surname:Acerini;given-names:CL</infon><infon key="name_5">surname:Boonen;given-names:SE</infon><infon key="name_6">surname:Dayanikli;given-names:P</infon><infon key="name_7">surname:Firth;given-names:HV</infon><infon key="name_8">surname:Goodship;given-names:JA</infon><infon key="name_9">surname:Haemers;given-names:AP</infon><infon key="pub-id_pmid">18622393</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2008</infon><offset>34913</offset><text>Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57</text></passage><passage><infon key="fpage">18091</infon><infon key="lpage">18097</infon><infon key="name_0">surname:Miao;given-names:F</infon><infon key="name_1">surname:Gonzalo;given-names:IG</infon><infon key="name_2">surname:Lanting;given-names:L</infon><infon key="name_3">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">14976218</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2004</infon><offset>35042</offset><text>In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions</text></passage><passage><infon key="fpage">1310</infon><infon key="lpage">1316</infon><infon key="name_0">surname:Hofmann;given-names:MA</infon><infon key="name_1">surname:Schiekofer;given-names:S</infon><infon key="name_10">surname:Bierhaus;given-names:A</infon><infon key="name_11">surname:Nawroth;given-names:PP</infon><infon key="name_2">surname:Kanitz;given-names:M</infon><infon key="name_3">surname:Klevesath;given-names:MS</infon><infon key="name_4">surname:Joswig;given-names:M</infon><infon key="name_5">surname:Lee;given-names:V</infon><infon key="name_6">surname:Morcos;given-names:M</infon><infon key="name_7">surname:Tritschler;given-names:H</infon><infon key="name_8">surname:Ziegler;given-names:R</infon><infon key="name_9">surname:Wahl;given-names:P</infon><infon key="pub-id_pmid">9702439</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Care</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">1998</infon><offset>35147</offset><text>Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes</text></passage><passage><infon key="fpage">1256</infon><infon key="lpage">1264</infon><infon key="name_0">surname:Shanmugam;given-names:N</infon><infon key="name_1">surname:Reddy;given-names:MA</infon><infon key="name_2">surname:Guha;given-names:M</infon><infon key="name_3">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">12716761</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2003</infon><offset>35309</offset><text>High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells</text></passage><passage><infon key="fpage">26771</infon><infon key="lpage">26781</infon><infon key="name_0">surname:Li;given-names:Y</infon><infon key="name_1">surname:Reddy;given-names:MA</infon><infon key="name_2">surname:Miao;given-names:F</infon><infon key="name_3">surname:Shanmugam;given-names:N</infon><infon key="name_4">surname:Yee;given-names:JK</infon><infon key="name_5">surname:Hawkins;given-names:D</infon><infon key="name_6">surname:Ren;given-names:B</infon><infon key="name_7">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">18650421</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">283</infon><infon key="year">2008</infon><offset>35408</offset><text>Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation</text></passage><passage><infon key="fpage">615</infon><infon key="lpage">623</infon><infon key="name_0">surname:Reddy;given-names:MA</infon><infon key="name_1">surname:Villeneuve;given-names:LM</infon><infon key="name_2">surname:Wang;given-names:M</infon><infon key="name_3">surname:Lanting;given-names:L</infon><infon key="name_4">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">18688044</infon><infon key="section_type">REF</infon><infon key="source">Circ Res</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2008</infon><offset>35567</offset><text>Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice</text></passage><passage><infon key="fpage">9047</infon><infon key="lpage">9052</infon><infon key="name_0">surname:Villeneuve;given-names:LM</infon><infon key="name_1">surname:Reddy;given-names:MA</infon><infon key="name_2">surname:Lanting;given-names:LL</infon><infon key="name_3">surname:Wang;given-names:M</infon><infon key="name_4">surname:Meng;given-names:L</infon><infon key="name_5">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">18579779</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">2008</infon><offset>35691</offset><text>Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes</text></passage><passage><infon key="fpage">3189</infon><infon key="lpage">3198</infon><infon key="name_0">surname:Miao;given-names:F</infon><infon key="name_1">surname:Smith;given-names:DD</infon><infon key="name_2">surname:Zhang;given-names:L</infon><infon key="name_3">surname:Min;given-names:A</infon><infon key="name_4">surname:Feng;given-names:W</infon><infon key="name_5">surname:Natarajan;given-names:R</infon><infon key="pub-id_pmid">18776137</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2008</infon><offset>35825</offset><text>Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes</text></passage><passage><infon key="fpage">2545</infon><infon key="lpage">2559</infon><infon key="name_0">surname:Gerstein;given-names:HC</infon><infon key="name_1">surname:Miller;given-names:ME</infon><infon key="name_10">surname:Probstfield;given-names:JL</infon><infon key="name_11">surname:Simons-Morton;given-names:DG</infon><infon key="name_12">surname:Friedewald;given-names:WT</infon><infon key="name_2">surname:Byington;given-names:RP</infon><infon key="name_3">surname:Goff;given-names:DC;suffix:Jr</infon><infon key="name_4">surname:Bigger;given-names:JT</infon><infon key="name_5">surname:Buse;given-names:JB</infon><infon key="name_6">surname:Cushman;given-names:WC</infon><infon key="name_7">surname:Genuth;given-names:S</infon><infon key="name_8">surname:Ismail-Beigi;given-names:F</infon><infon key="name_9">surname:Grimm;given-names:RH;suffix:Jr</infon><infon key="pub-id_pmid">18539917</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">358</infon><infon key="year">2008</infon><offset>35979</offset><text>Effects of intensive glucose lowering in type 2 diabetes</text></passage><passage><infon key="fpage">2560</infon><infon key="lpage">2572</infon><infon key="name_0">surname:Patel;given-names:A</infon><infon key="name_1">surname:MacMahon;given-names:S</infon><infon key="name_10">surname:Hamet;given-names:P</infon><infon key="name_11">surname:Harrap;given-names:S</infon><infon key="name_12">surname:Heller;given-names:S</infon><infon key="name_13">surname:Liu;given-names:L</infon><infon key="name_14">surname:Mancia;given-names:G</infon><infon key="name_15">surname:Mogensen;given-names:CE</infon><infon key="name_16">surname:Pan;given-names:C</infon><infon key="name_17">surname:Poulter;given-names:N</infon><infon key="name_18">surname:Rodgers;given-names:A</infon><infon key="name_19">surname:Williams;given-names:B</infon><infon key="name_2">surname:Chalmers;given-names:J</infon><infon key="name_20">surname:Bompoint;given-names:S</infon><infon key="name_21">surname:de Galan;given-names:BE</infon><infon key="name_22">surname:Joshi;given-names:R</infon><infon key="name_23">surname:Travert;given-names:F</infon><infon key="name_3">surname:Neal;given-names:B</infon><infon key="name_4">surname:Billot;given-names:L</infon><infon key="name_5">surname:Woodward;given-names:M</infon><infon key="name_6">surname:Marre;given-names:M</infon><infon key="name_7">surname:Cooper;given-names:M</infon><infon key="name_8">surname:Glasziou;given-names:P</infon><infon key="name_9">surname:Grobbee;given-names:D</infon><infon key="pub-id_pmid">18539916</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">358</infon><infon key="year">2008</infon><offset>36036</offset><text>Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes</text></passage><passage><infon key="fpage">968</infon><infon key="lpage">983</infon><infon key="pub-id_pmid">7622004</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">1995</infon><offset>36123</offset><text>The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial</text></passage><passage><infon key="fpage">2409</infon><infon key="lpage">2417</infon><infon key="name_0">surname:El-Osta;given-names:A</infon><infon key="name_1">surname:Brasacchio;given-names:D</infon><infon key="name_2">surname:Yao;given-names:D</infon><infon key="name_3">surname:Pocai;given-names:A</infon><infon key="name_4">surname:Jones;given-names:PL</infon><infon key="name_5">surname:Roeder;given-names:RG</infon><infon key="name_6">surname:Cooper;given-names:ME</infon><infon key="name_7">surname:Brownlee;given-names:M</infon><infon key="pub-id_pmid">18809715</infon><infon key="section_type">REF</infon><infon key="source">J Exp Med</infon><infon key="type">ref</infon><infon key="volume">205</infon><infon key="year">2008</infon><offset>36275</offset><text>Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia</text></passage><passage><infon key="fpage">1229</infon><infon key="lpage">1236</infon><infon key="name_0">surname:Brasacchio;given-names:D</infon><infon key="name_1">surname:Okabe;given-names:J</infon><infon key="name_2">surname:Tikellis;given-names:C</infon><infon key="name_3">surname:Balcerczyk;given-names:A</infon><infon key="name_4">surname:George;given-names:P</infon><infon key="name_5">surname:Baker;given-names:EK</infon><infon key="name_6">surname:Calkin;given-names:AC</infon><infon key="name_7">surname:Brownlee;given-names:M</infon><infon key="name_8">surname:Cooper;given-names:ME</infon><infon key="name_9">surname:El-Osta;given-names:A</infon><infon key="pub-id_pmid">19208907</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2009</infon><offset>36395</offset><text>Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail</text></passage><passage><infon key="fpage">243</infon><infon key="lpage">263</infon><infon key="name_0">surname:Szyf;given-names:M</infon><infon key="pub-id_pmid">18851683</infon><infon key="section_type">REF</infon><infon key="source">Annu Rev Pharmacol Toxicol</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2009</infon><offset>36567</offset><text>Epigenetics, DNA methylation, and chromatin modifying drugs</text></passage><passage><infon key="fpage">1402</infon><infon key="lpage">1413</infon><infon key="name_0">surname:Bieliauskas;given-names:AV</infon><infon key="name_1">surname:Pflum;given-names:MK</infon><infon key="pub-id_pmid">18568166</infon><infon key="section_type">REF</infon><infon key="source">Chem Soc Rev</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2008</infon><offset>36627</offset><text>Isoform-selective histone deacetylase inhibitors</text></passage><passage><infon key="fpage">3549</infon><infon key="lpage">3560</infon><infon key="name_0">surname:Granger;given-names:A</infon><infon key="name_1">surname:Abdullah;given-names:I</infon><infon key="name_2">surname:Huebner;given-names:F</infon><infon key="name_3">surname:Stout;given-names:A</infon><infon key="name_4">surname:Wang;given-names:T</infon><infon key="name_5">surname:Huebner;given-names:T</infon><infon key="name_6">surname:Epstein;given-names:JA</infon><infon key="name_7">surname:Gruber;given-names:PJ</infon><infon key="pub-id_pmid">18606865</infon><infon key="section_type">REF</infon><infon key="source">Faseb J</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2008</infon><offset>36676</offset><text>Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice</text></passage></document></collection>
